id.exposure	id.outcome	outcome	exposure	method	Q	Q_df	Q_pval
0kjQy1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	79.3074423767217	55	0.0176260794133777
0kjQy1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	MR Egger	77.4309427442556	54	0.0199663324119973
0kjQy1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	79.3365339264497	55	0.0175315577797718
0kjQy1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0705003102267661	55	1
0kjQy1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	69.3154395313613	55	0.0927338252936591
0kjQy1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	MR Egger	66.7721547957335	54	0.113785547644111
0kjQy1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	69.3291641779853	55	0.0925476709505017
0kjQy1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0719595702818094	55	1
0kjQy1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	65.771883500125	54	0.130791099361646
0kjQy1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	MR Egger	61.6290189132094	53	0.194756805445818
0kjQy1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	65.8288540284104	54	0.129773001289223
0kjQy1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.507809060905729	54	1
0PtPNH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	Maximum likelihood	63.4393227326764	51	0.113413972226048
0PtPNH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	MR Egger	57.7309208022476	50	0.211158527503346
0PtPNH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	Inverse variance weighted	63.4745982428808	51	0.112834620436696
0PtPNH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0555901635038782	51	1
0PtPNH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	Maximum likelihood	58.218361302112	51	0.226968180758201
0PtPNH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	MR Egger	50.2677836057192	50	0.462780671912776
0PtPNH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	Inverse variance weighted	58.2411138053023	51	0.226347481124399
0PtPNH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0805957021988629	51	1
0PtPNH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	Maximum likelihood	57.4352415884326	51	0.249011477301097
0PtPNH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	MR Egger	57.3588714598006	50	0.22108036430367
0PtPNH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	Inverse variance weighted	57.5623420024087	51	0.245344469951175
0PtPNH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int_imputed.txt_snps.txt	Unweighted regression	0.753940887407443	51	1
0RvEIF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	86.976541017265	66	0.0428545954792979
0RvEIF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	MR Egger	85.4337917182851	65	0.0455301856488318
0RvEIF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	87.0170603521179	66	0.0425876080149029
0RvEIF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0742171802118057	66	1
0RvEIF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	85.5727331962337	66	0.05302990813757
0RvEIF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	MR Egger	85.3513179598229	65	0.0461108360046247
0RvEIF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	85.6898208650778	66	0.0521094705436174
0RvEIF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.104070423309877	66	1
0RvEIF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	82.0773865241826	65	0.0747947735738082
0RvEIF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	MR Egger	76.3937368697007	64	0.137884639218076
0RvEIF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	82.0864709445014	65	0.0746984227202269
0RvEIF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.59621291306793	65	1
0XQiAv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.2572782568548	54	0.106185502644166
0XQiAv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	67.3318790291084	53	0.0890341572809101
0XQiAv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.3467711574207	54	0.104828304953593
0XQiAv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0904031330801892	54	1
0XQiAv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.577099908336	54	0.153569535205077
0XQiAv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	64.5524536772375	53	0.132795220911455
0XQiAv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.6223478880311	54	0.152656440549267
0XQiAv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.114638642307508	54	1
0XQiAv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.6526167860363	52	0.0711580379573223
0XQiAv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	67.7356233214479	51	0.0583710302471044
0XQiAv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.0165341099507	52	0.0671788684752547
0XQiAv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.772360647346789	52	1
1DPTgB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	Maximum likelihood	109.979554536524	47	5.82760065227372e-07
1DPTgB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	MR Egger	106.297073657682	46	1.12493125364337e-06
1DPTgB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	Inverse variance weighted	109.982966333416	47	5.82161583063023e-07
1DPTgB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int_imputed.txt_snps.txt	Unweighted regression	0.0762200643156613	47	1
1DPTgB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	Maximum likelihood	94.5984643595042	47	4.7842639213609e-05
1DPTgB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	MR Egger	92.0012049159021	46	6.61419171224742e-05
1DPTgB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	Inverse variance weighted	94.6140396751343	47	4.76414190068691e-05
1DPTgB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int_imputed.txt_snps.txt	Unweighted regression	0.134825652110227	47	1
1DPTgB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	Maximum likelihood	60.869466709968	46	0.0698529219672975
1DPTgB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	MR Egger	60.8681395677613	45	0.0573828525504701
1DPTgB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	Inverse variance weighted	60.8810790501127	46	0.0697182534736947
1DPTgB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int_imputed.txt_snps.txt	Unweighted regression	0.391166552198328	46	1
1gs7ZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	94.2770954730063	60	0.00312000791844224
1gs7ZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	MR Egger	91.6741430021973	59	0.00411919465585978
1gs7ZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	94.3079811596903	60	0.00310020190372522
1gs7ZT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.084314978512723	60	1
1gs7ZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	81.1169052814823	60	0.0360656689233063
1gs7ZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	MR Egger	75.9686847455826	59	0.0676657474881367
1gs7ZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	81.1259905319454	60	0.0360118995768128
1gs7ZT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0912910554870281	60	1
1gs7ZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	69.8279369360589	58	0.137351595488451
1gs7ZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	MR Egger	66.4090779743005	57	0.184427462157563
1gs7ZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	69.8698012958693	58	0.136598574138249
1gs7ZT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.502531564384998	58	1
1M1hDZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	30.6923533697326	27	0.283957800963884
1M1hDZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	30.4553148781359	26	0.249178842622408
1M1hDZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	30.7074801743004	27	0.283318770992592
1M1hDZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0294357866796141	27	1
1M1hDZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	32.7954494138212	27	0.203904192699126
1M1hDZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	31.3668250709602	26	0.214890343902815
1M1hDZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	32.8257773753862	27	0.202880311048207
1M1hDZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.050902928802712	27	1
1M1hDZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	22.1247620255528	25	0.628529724165522
1M1hDZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	22.0903411809269	24	0.573874551811493
1M1hDZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	22.1268313260922	25	0.628409910398746
1M1hDZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.229417512336899	25	1
1SpEtQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	28.0589276147813	23	0.213561466076409
1SpEtQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	MR Egger	28.0687520604264	22	0.173413881823064
1SpEtQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	28.0897321389713	23	0.212407404175844
1SpEtQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0373296142951269	23	1
1SpEtQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	25.6933441024642	23	0.315554940879153
1SpEtQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	MR Egger	25.4508444113854	22	0.276004525424348
1SpEtQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	25.7089612771317	23	0.314796713433294
1SpEtQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0425334377364586	23	1
1SpEtQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	29.6196838058441	21	0.099901045722598
1SpEtQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	MR Egger	29.4912807936387	20	0.0785267973015555
1SpEtQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	29.6484708374173	21	0.099282878594882
1SpEtQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.660425404642969	21	0.999999999999449
1UogBn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	Maximum likelihood	35.8333612920308	5	1.02556494129887e-06
1UogBn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	MR Egger	35.496020311285	4	3.67360370800556e-07
1UogBn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	Inverse variance weighted	37.0941795708913	5	5.73465822049118e-07
1UogBn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int_imputed.txt_snps.txt	Unweighted regression	0.00974871866518999	5	0.999999502599974
1UogBn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	Maximum likelihood	31.1208152663099	5	8.86653092481823e-06
1UogBn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	MR Egger	31.7947993503211	4	2.10701157314458e-06
1UogBn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	Inverse variance weighted	32.465285976589	5	4.80488227557949e-06
1UogBn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int_imputed.txt_snps.txt	Unweighted regression	0.0120719170150329	5	0.999999151958027
1UogBn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	Maximum likelihood	8.65987560925293	5	0.123424150920708
1UogBn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	MR Egger	6.47189561097881	4	0.166569823105532
1UogBn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	Inverse variance weighted	8.68071204416017	5	0.122497463540962
1UogBn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int_imputed.txt_snps.txt	Unweighted regression	0.0176105496234296	5	0.999997824543743
2afIIC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	111.83387365717	71	0.00143096437492424
2afIIC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	MR Egger	110.8888496864	70	0.00134399362617005
2afIIC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	111.846996750825	71	0.00142714807764107
2afIIC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.147668878294591	71	1
2afIIC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	105.149262256916	71	0.00527109871298555
2afIIC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	MR Egger	105.138234720266	70	0.0041979063592104
2afIIC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	105.150560183844	71	0.00526982394229606
2afIIC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.229532780516558	71	1
2afIIC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	82.0430743385177	67	0.102054936909902
2afIIC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	MR Egger	76.7107989154159	66	0.172727576609923
2afIIC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	82.0994891996392	67	0.101298509222385
2afIIC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.557790678539061	67	1
2e8wsL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	86.7357277397616	57	0.00676003154664619
2e8wsL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	MR Egger	86.0235286725824	56	0.00608913961293403
2e8wsL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	86.8304605161358	57	0.00663391160051037
2e8wsL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.11860996229285	57	1
2e8wsL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	97.203013974017	57	0.000719717211565312
2e8wsL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	MR Egger	97.2793871551984	56	0.000523365377697886
2e8wsL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	97.3070452068314	57	0.000702808324008014
2e8wsL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.199395076594252	57	1
2e8wsL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	71.3336180468292	54	0.0571086831475153
2e8wsL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	MR Egger	69.6453910582095	53	0.0622341109820978
2e8wsL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	71.337034382698	54	0.057077365918695
2e8wsL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.807367609074121	54	1
2v7fB6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.50815034645	45	0.00578056105816259
2v7fB6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	72.5089385654963	44	0.00435389048793402
2v7fB6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.5297210420658	45	0.00575326999570844
2v7fB6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0763702192319807	45	1
2v7fB6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.5749121304229	45	0.00290317078717331
2v7fB6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	75.3619903426475	44	0.00225684798452877
2v7fB6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.5771399269105	45	0.00290168572609351
2v7fB6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.122453401654901	45	1
2v7fB6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	45.9909109111666	43	0.349418330969842
2v7fB6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	45.5471735704898	42	0.326728733880352
2v7fB6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.1610425784728	43	0.342962614921268
2v7fB6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.484245513818633	43	1
33mYdE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	51.6810731222054	50	0.40795641064423
33mYdE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	51.5161486686124	49	0.375594982756401
33mYdE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	51.6824716138461	50	0.407903353043326
33mYdE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.05301430526683	50	1
33mYdE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	52.088916123123	50	0.392598432930207
33mYdE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	51.9450012363342	49	0.359868824483891
33mYdE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	52.0890581731153	50	0.392593125213716
33mYdE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.090272980384176	50	1
33mYdE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	44.3803600169608	49	0.660647768047745
33mYdE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	44.4026768699477	48	0.621036429016605
33mYdE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	44.406354610113	49	0.659621200689088
33mYdE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.496762038389479	49	1
3BhayH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	71.4505028097751	51	0.0308747371047504
3BhayH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	66.9483408461663	50	0.054897631563375
3BhayH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	71.5046446686616	51	0.0305770450725814
3BhayH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0600185501449865	51	1
3BhayH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.0051388774144	51	0.104398870446352
3BhayH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	61.5137085105533	50	0.12739664384345
3BhayH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.0200461013039	51	0.104169270160605
3BhayH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0845892949963432	51	1
3BhayH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.7886774644485	49	0.159609525303933
3BhayH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	57.7656779196105	48	0.157887960819562
3BhayH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	58.9031542081024	49	0.157136376163206
3BhayH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.338216554003795	49	1
3CNu6i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	Maximum likelihood	84.4504394411662	43	0.000163681619710177
3CNu6i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	MR Egger	83.6576622085939	42	0.000139411095237355
3CNu6i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	Inverse variance weighted	84.5141275397853	43	0.000160921871011657
3CNu6i	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int_imputed.txt_snps.txt	Unweighted regression	0.0614694120428859	43	1
3CNu6i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	Maximum likelihood	79.4487696095279	43	0.000601546700103264
3CNu6i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	MR Egger	78.537186897741	42	0.000537636900272125
3CNu6i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	Inverse variance weighted	79.4839493254087	43	0.000596208970874813
3CNu6i	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int_imputed.txt_snps.txt	Unweighted regression	0.0875938231229864	43	1
3CNu6i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	Maximum likelihood	45.934266102755	41	0.275102379981674
3CNu6i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	MR Egger	42.4901294049028	40	0.364267593780259
3CNu6i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	Inverse variance weighted	45.9345510622182	41	0.275092653941914
3CNu6i	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int_imputed.txt_snps.txt	Unweighted regression	0.251487983502793	41	1
3g5Dl3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	41.5324963525987	23	0.0102859320709448
3g5Dl3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	41.3119517630458	22	0.00756417815219581
3g5Dl3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	41.5466671403009	23	0.0102472357191501
3g5Dl3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0410299945333951	23	1
3g5Dl3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.4787836155769	23	0.028948728790348
3g5Dl3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	37.307833597665	22	0.0218797006174771
3g5Dl3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.4806066305841	23	0.0289358562126506
3g5Dl3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0530203380699104	23	1
3g5Dl3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.1293609959653	22	0.246169375014449
3g5Dl3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	26.230849918239	21	0.197783167457292
3g5Dl3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.3772324473053	22	0.235838414916491
3g5Dl3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.256802516795077	22	1
3grbqV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	77.5998427859151	44	0.00132340212474778
3grbqV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	MR Egger	76.7768163597593	43	0.00117130057741006
3grbqV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	77.7020185108994	44	0.0012910615429056
3grbqV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0509078698994078	44	1
3grbqV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	65.0322636956737	44	0.0212441933605639
3grbqV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	MR Egger	64.2568688547553	43	0.0194400736384763
3grbqV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	65.1157463772875	44	0.0208962460128563
3grbqV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0708874753469287	44	1
3grbqV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	57.1415541383358	43	0.0729558266404345
3grbqV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	MR Egger	46.033460489419	42	0.308890725999842
3grbqV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	57.357335524279	43	0.0703256580461063
3grbqV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.369440474979579	43	1
3jnRlc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.1219209662447	54	0.359906274671255
3jnRlc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	57.124047688269	53	0.324546480542304
3jnRlc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.1249462733205	54	0.359801485485868
3jnRlc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0642382400841662	54	1
3jnRlc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.7905738788697	54	0.192896095546571
3jnRlc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	62.8009011851548	53	0.167835643641534
3jnRlc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.8009725742855	54	0.192648460691142
3jnRlc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.108091381619407	54	1
3jnRlc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.5532406541227	53	0.0999261254441844
3jnRlc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	66.4084137708641	52	0.0862617651526479
3jnRlc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.6230666262596	53	0.0989078453683189
3jnRlc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.652486486604012	53	1
3PQfru	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	54.4417577118832	39	0.0512328038937836
3PQfru	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	MR Egger	54.2772817767541	38	0.0421479940247866
3PQfru	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	54.4518025908267	39	0.0511369705765808
3PQfru	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0364240246751401	39	1
3PQfru	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	48.8854087156945	39	0.133338520252918
3PQfru	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	MR Egger	48.8613076004786	38	0.111492655104654
3PQfru	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	48.9009331564785	39	0.133013324596644
3PQfru	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.058950763262162	39	1
3PQfru	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	37.8707568424991	39	0.521276741779558
3PQfru	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	MR Egger	36.0297565031471	38	0.560852424475794
3PQfru	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	37.9110156031515	39	0.519427873899307
3PQfru	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.265197342616405	39	1
3Zf4pm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	Maximum likelihood	28.3439195242851	18	0.0570106997965665
3Zf4pm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	MR Egger	23.9133643456383	17	0.121808108491381
3Zf4pm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	Inverse variance weighted	28.3452379618665	18	0.0569920754057738
3Zf4pm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int_imputed.txt_snps.txt	Unweighted regression	0.0115880178511183	18	1
3Zf4pm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	Maximum likelihood	18.9872275338967	18	0.392610409137176
3Zf4pm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	MR Egger	17.1771787862736	17	0.44242604618257
3Zf4pm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	Inverse variance weighted	18.9901470056647	18	0.392430467246521
3Zf4pm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int_imputed.txt_snps.txt	Unweighted regression	0.0135004074789742	18	1
3Zf4pm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	Maximum likelihood	17.4423120764266	18	0.492918100376531
3Zf4pm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	MR Egger	9.88245134403527	17	0.908467147450768
3Zf4pm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	Inverse variance weighted	17.558465114944	18	0.485075599038337
3Zf4pm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int_imputed.txt_snps.txt	Unweighted regression	0.13393722966685	18	1
41gilM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	60.259713465079	43	0.0420146796376829
41gilM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	MR Egger	60.1397594058565	42	0.0343582984832144
41gilM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.2751830167769	43	0.0418951513070523
41gilM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0455663317427978	43	1
41gilM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.4298811432943	43	0.132339233711364
41gilM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	MR Egger	52.2247898081581	42	0.134027060068057
41gilM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.4301480789633	43	0.132333899987479
41gilM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0589883954530974	43	1
41gilM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6219245533005	43	0.0472069305639037
41gilM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	MR Egger	59.0955242322163	42	0.0418254690073642
41gilM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.621939059582	43	0.0472068064422156
41gilM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.51746384963408	43	1
4MwqX4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	Maximum likelihood	8.08814477090022	5	0.151444235000678
4MwqX4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	MR Egger	7.87580573646595	4	0.0962350013806752
4MwqX4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	Inverse variance weighted	8.09207763379658	5	0.15123352553327
4MwqX4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int_imputed.txt_snps.txt	Unweighted regression	0.00457176043961389	5	0.999999924950394
4MwqX4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	Maximum likelihood	3.33850248640036	5	0.647952324631285
4MwqX4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	MR Egger	3.11232120202632	4	0.539207810832019
4MwqX4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	Inverse variance weighted	3.34584276257944	5	0.646830820608857
4MwqX4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int_imputed.txt_snps.txt	Unweighted regression	0.00434102819376346	5	0.999999934058769
4MwqX4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	Maximum likelihood	3.86041803960623	3	0.27693628163069
4MwqX4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	MR Egger	3.85182818264183	2	0.145742474018576
4MwqX4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	Inverse variance weighted	3.86563020145922	3	0.276343974868801
4MwqX4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int_imputed.txt_snps.txt	Unweighted regression	0.0108769640146253	3	0.999699279078735
4rlSC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.2869327188879	32	0.105522691897075
4rlSC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	39.6455435776679	31	0.137230371507453
4rlSC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.3254661541658	32	0.104794502698366
4rlSC1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0678844106225241	32	1
4rlSC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.4231069338648	32	0.27032515824073
4rlSC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	35.7944202095588	31	0.253402663618087
4rlSC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.4322922679753	32	0.269977288105183
4rlSC1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0803553737266825	32	1
4rlSC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.7542978530513	32	0.25796107077266
4rlSC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	35.9116660756582	31	0.249102009774881
4rlSC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.8386591728637	32	0.25487074987656
4rlSC1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.492265713847034	32	1
54qhRR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	36.0269360662747	48	0.898298906913094
54qhRR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	35.4109285789691	47	0.8925734413328
54qhRR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	36.030135994805	48	0.898228550949254
54qhRR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0489392308454169	48	1
54qhRR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	43.6930740722149	48	0.649816844566598
54qhRR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	40.8319260421388	47	0.724664164062727
54qhRR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	43.6931632456121	48	0.649813257983979
54qhRR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0910507486282514	48	1
54qhRR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6162169375929	48	0.121332517656686
54qhRR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	59.033547969252	47	0.111959589380776
54qhRR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.6202199870843	48	0.121261238615017
54qhRR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.720665909857094	48	1
5aTQwp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.2349395403355	43	0.208605311793419
5aTQwp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	48.2988948134863	42	0.233432750905728
5aTQwp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.2618826855708	43	0.207854799220611
5aTQwp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0581306696173081	43	1
5aTQwp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	68.035772998896	43	0.00883512274181517
5aTQwp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	68.0018111385588	42	0.00674850500204881
5aTQwp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.0694064984459	43	0.00877116961080286
5aTQwp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.137836561910867	43	1
5aTQwp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.128064869285	42	0.8010272343392
5aTQwp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	27.716670520699	41	0.943894790828258
5aTQwp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.1285901791993	42	0.801008865190449
5aTQwp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.230233109546187	42	1
5c0ZH2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.5585181216583	47	0.139100927760911
5c0ZH2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	57.1301284104675	46	0.125812363788579
5c0ZH2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.5945166344589	47	0.13838354850457
5c0ZH2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0667044234781142	47	1
5c0ZH2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	68.7597751164274	47	0.0208916183898023
5c0ZH2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	68.7452269974606	46	0.0165022476184998
5c0ZH2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.795129600129	47	0.0207494926767745
5c0ZH2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.110900513534319	47	1
5c0ZH2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.6792635294755	45	0.403233530669542
5c0ZH2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	41.9592011994965	44	0.559454814089877
5c0ZH2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.7827737960946	45	0.399124682373864
5c0ZH2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.378162308760403	45	1
5F3A46	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	92.8426724829235	51	0.000310337721314371
5F3A46	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	MR Egger	91.9282792834223	50	0.000279211728958496
5F3A46	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	92.8606345826353	51	0.000308966984656902
5F3A46	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0763140673974613	51	1
5F3A46	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	90.4460764055646	51	0.000556034762724301
5F3A46	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	MR Egger	90.1884333422309	50	0.000429027638017774
5F3A46	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	90.4645324101276	51	0.00055357505817797
5F3A46	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.115971158360799	51	1
5F3A46	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	62.8712253814708	50	0.104524818262474
5F3A46	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	MR Egger	55.8652228954266	49	0.232641282481961
5F3A46	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	62.9327922017583	50	0.103570172148863
5F3A46	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.400668604936758	50	1
5h7Rye	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.3079008414951	50	0.113587173100039
5h7Rye	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	MR Egger	61.1628766094465	49	0.113971430812255
5h7Rye	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.3129044893703	50	0.113504044101979
5h7Rye	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0669398353487796	50	1
5h7Rye	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	60.8779608504401	50	0.139355382903595
5h7Rye	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	MR Egger	58.4515431858604	49	0.167059186333013
5h7Rye	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	60.8855829034171	50	0.139207130268272
5h7Rye	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0976712993225044	50	1
5h7Rye	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	60.7107766903183	50	0.142637340176596
5h7Rye	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	MR Egger	60.5960941987852	49	0.123814656695848
5h7Rye	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	60.7386652930329	50	0.142085849329293
5h7Rye	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.74928025310407	50	1
5N3Xyj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	65.2147009842721	45	0.0259567622802529
5N3Xyj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	64.277119720901	44	0.0246350059314182
5N3Xyj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	65.2409980836247	45	0.0258261726751761
5N3Xyj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0486159820644521	45	1
5N3Xyj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	67.0523001250371	45	0.018124102180206
5N3Xyj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	67.0168746880356	44	0.0142385639831451
5N3Xyj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	67.0851027989446	45	0.0180060588850057
5N3Xyj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0833035936750525	45	1
5N3Xyj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	52.64329520317	44	0.174330912722671
5N3Xyj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	46.8759081373641	43	0.316517919177421
5N3Xyj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	52.680584683765	44	0.173425969053625
5N3Xyj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.41979204539502	44	1
5rZ5eH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.1158069076845	46	0.0475496957274697
5rZ5eH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	62.9004217141562	45	0.0400042380367549
5rZ5eH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.1418909851571	46	0.047331585020039
5rZ5eH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0983187823313936	46	1
5rZ5eH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.7938445739038	46	0.0503137879701009
5rZ5eH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	62.789271117684	45	0.0408205689633937
5rZ5eH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.7938599779432	46	0.0503136525000947
5rZ5eH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.132214909201664	46	1
5rZ5eH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	44.3129189031852	41	0.333721147748319
5rZ5eH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	42.0262994183476	40	0.383177517875013
5rZ5eH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	44.3446015167093	41	0.332515247602367
5rZ5eH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.434101932357782	41	1
5Utc9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	58.4204675421455	39	0.023512855887208
5Utc9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	MR Egger	58.4384843393799	38	0.0181104238404037
5Utc9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	58.4701276962655	39	0.023274790935669
5Utc9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0402052616791346	39	1
5Utc9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	46.4099664279594	39	0.193372030075004
5Utc9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	MR Egger	46.3495538051004	38	0.165852672219493
5Utc9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	46.4611096050786	39	0.191962004883845
5Utc9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.046333409077174	39	1
5Utc9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	38.0516364437451	38	0.467133230402689
5Utc9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	MR Egger	34.898227267742	37	0.567944807929613
5Utc9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	38.1826920717174	38	0.461181070616831
5Utc9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.221573481374937	38	1
5WGDMD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	Maximum likelihood	73.9676766889924	28	5.09799176049555e-06
5WGDMD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	MR Egger	66.8779958130521	27	3.09177381140334e-05
5WGDMD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	Inverse variance weighted	73.9934857703343	28	5.05464815458488e-06
5WGDMD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int_imputed.txt_snps.txt	Unweighted regression	0.108267150039626	28	1
5WGDMD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	Maximum likelihood	60.319779362266	28	0.000370662720748882
5WGDMD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	MR Egger	56.4816650809229	27	0.00074801152469505
5WGDMD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	Inverse variance weighted	60.346801022354	28	0.000367717984411173
5WGDMD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int_imputed.txt_snps.txt	Unweighted regression	0.113717343621617	28	1
5WGDMD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	Maximum likelihood	24.4316898356954	27	0.606277804204692
5WGDMD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	MR Egger	24.433388862912	26	0.551198367218737
5WGDMD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	Inverse variance weighted	24.5466236041089	27	0.599853530202728
5WGDMD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int_imputed.txt_snps.txt	Unweighted regression	0.234844782913376	27	1
6CBdaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	Maximum likelihood	13.5463365993779	13	0.406550152335519
6CBdaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	MR Egger	13.3721009301514	12	0.342584741529006
6CBdaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	Inverse variance weighted	13.5881551150213	13	0.403473574967015
6CBdaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int_imputed.txt_snps.txt	Unweighted regression	0.00834731973997534	13	1
6CBdaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	Maximum likelihood	14.8396345092037	13	0.317470785470812
6CBdaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	MR Egger	14.566897635208	12	0.26597982007989
6CBdaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	Inverse variance weighted	14.8666393089017	13	0.315752051189783
6CBdaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int_imputed.txt_snps.txt	Unweighted regression	0.015665610452856	13	1
6CBdaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	Maximum likelihood	5.71839391061273	13	0.955804018037889
6CBdaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	MR Egger	4.96135026053697	12	0.959257424262927
6CBdaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	Inverse variance weighted	5.7190780192735	13	0.95578201142646
6CBdaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int_imputed.txt_snps.txt	Unweighted regression	0.0262722027742059	13	1
6fB5zI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	63.3291394541614	39	0.00817725185416366
6fB5zI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	MR Egger	63.1907848599399	38	0.00630107455973912
6fB5zI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	63.3394531225983	39	0.00815828827789205
6fB5zI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0560400215355853	39	1
6fB5zI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	61.0836376503092	39	0.0134213196740885
6fB5zI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	MR Egger	60.9752387684612	38	0.0104260306312294
6fB5zI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	61.0836676098203	39	0.0134212327671004
6fB5zI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.128168922497607	39	1
6fB5zI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.4427923772305	39	0.0615654124195958
6fB5zI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	MR Egger	50.9611671106767	38	0.077862277501359
6fB5zI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.4561474666961	39	0.0614163908907557
6fB5zI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.508141451893431	39	1
6gkF66	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	83.237497358482	43	0.000225824354986289
6gkF66	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	81.7169080638106	42	0.000234472748802634
6gkF66	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	83.2565106524284	43	0.000224694655957922
6gkF66	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0666939392698652	43	1
6gkF66	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	78.5117005293223	43	0.000761734967645142
6gkF66	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	77.7030613013311	42	0.000665243723073408
6gkF66	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	78.548650319416	43	0.000754713018397767
6gkF66	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.109209728905947	43	1
6gkF66	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	42.9020126044369	41	0.389621488007605
6gkF66	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	35.9772310402132	40	0.651925282370138
6gkF66	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	42.9433778645479	41	0.387925290652827
6gkF66	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.280294914233875	41	1
6Kq5Df	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.0903630626332	37	0.00602912284200973
6Kq5Df	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	MR Egger	61.0952048157813	36	0.00561546747334301
6Kq5Df	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.0903860957504	37	0.00602909027484545
6Kq5Df	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0538088660083083	37	1
6Kq5Df	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	58.3190472934755	37	0.0141938536283103
6Kq5Df	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	MR Egger	56.5545751316835	36	0.0158713068159437
6Kq5Df	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	58.3243933008372	37	0.0141772227387397
6Kq5Df	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0884788243527241	37	1
6Kq5Df	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	38.8989033903	35	0.298463134177263
6Kq5Df	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	MR Egger	32.1567568929025	34	0.55818640340748
6Kq5Df	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	38.9181321100353	35	0.297721594687119
6Kq5Df	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.245409969511482	35	1
7bpoqR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	85.15753060301	46	0.00039511514630147
7bpoqR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	MR Egger	81.3632904675491	45	0.000729186795306465
7bpoqR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	85.1851282226498	46	0.000392372611933409
7bpoqR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0694337485671179	46	1
7bpoqR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	76.6374813663918	46	0.00305693374856895
7bpoqR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	MR Egger	75.2522140631884	45	0.00312597824578421
7bpoqR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	76.6873658190763	46	0.00302247553069252
7bpoqR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.069457195926762	46	1
7bpoqR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	57.6987164038085	45	0.0969972581339883
7bpoqR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	MR Egger	49.7205541885234	44	0.256030888184941
7bpoqR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	57.7246345078074	45	0.0966004517551801
7bpoqR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.349341687765869	45	1
7kpC10	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	Maximum likelihood	43.4211114075701	38	0.251360775001643
7kpC10	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	MR Egger	42.7508598712077	37	0.237808942930653
7kpC10	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	43.42144725311	38	0.251349553145103
7kpC10	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0400016268411457	38	1
7kpC10	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	Maximum likelihood	35.390969772816	38	0.590722121823971
7kpC10	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	MR Egger	34.0895550379826	37	0.606235216989124
7kpC10	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	35.3979037686759	38	0.590398454808892
7kpC10	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.048141102868515	38	1
7kpC10	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	Maximum likelihood	42.6040714195473	37	0.242629853950697
7kpC10	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	MR Egger	42.5305822648773	36	0.210402126570739
7kpC10	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	42.6059110873691	37	0.242569040817741
7kpC10	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.316019561404432	37	1
7LTDBz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	48.9529603412744	28	0.00844343683685536
7LTDBz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	MR Egger	47.7009433245406	27	0.00829022083664653
7LTDBz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	48.9689733315583	28	0.00840938948333701
7LTDBz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0298648083157393	28	1
7LTDBz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	40.7967855207475	28	0.0560525734556994
7LTDBz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	MR Egger	40.5279349627665	27	0.0456915125188812
7LTDBz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	40.8130077147419	28	0.0558620280854516
7LTDBz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0451533110594951	28	1
7LTDBz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	26.0292964583466	28	0.57143414218133
7LTDBz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	MR Egger	23.2289872623259	27	0.672651316584775
7LTDBz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	26.0694376648618	28	0.569227638267178
7LTDBz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.290347580370411	28	1
7ML0LT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	60.1102980724289	51	0.179186748814121
7ML0LT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	59.6551388663273	50	0.164714017174684
7ML0LT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	60.1164146572536	51	0.179044817172582
7ML0LT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0773172863825081	51	1
7ML0LT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	54.2579795114475	51	0.35134497833418
7ML0LT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	54.1647201192215	50	0.318563192950681
7ML0LT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	54.2618396485564	51	0.351209090385366
7ML0LT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0931045863649401	51	1
7ML0LT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	56.4646801426242	50	0.246174517237815
7ML0LT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	56.427698711117	49	0.217097632474181
7ML0LT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	56.5472800291722	50	0.243783009020251
7ML0LT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.816301277585998	50	1
7v8Hs4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	68.5658777235489	54	0.0876776625666798
7v8Hs4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	68.7039031120381	53	0.0721934408633112
7v8Hs4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	68.7044918891442	54	0.0858802082068151
7v8Hs4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0687495407835273	54	1
7v8Hs4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	62.6136453725094	54	0.197143417202316
7v8Hs4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	62.6916527949469	53	0.170225590467829
7v8Hs4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	62.6937839128052	54	0.195211676807002
7v8Hs4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.110810053493442	54	1
7v8Hs4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	78.7824079101831	52	0.00967314637405405
7v8Hs4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	76.9027113162427	51	0.0110134347670251
7v8Hs4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	78.7830574060801	52	0.00967189186490908
7v8Hs4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.774283080783204	52	1
7z7zVv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.0958917551048	49	0.22618078686089
7z7zVv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	55.8654528583132	48	0.203294845646078
7z7zVv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	56.1536630327081	49	0.2245814791022
7z7zVv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0329801146118628	49	1
7z7zVv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.0404001111363	49	0.227724056355696
7z7zVv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	55.7815644855375	48	0.205489471982203
7z7zVv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	56.0842102567162	49	0.226505083684774
7z7zVv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0523398612188973	49	1
7z7zVv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	49.8386817761997	47	0.361075796738454
7z7zVv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	49.4113595797568	46	0.338563498163203
7z7zVv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	49.9611831668608	47	0.356543896778254
7z7zVv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.368723268195384	47	1
8DumKD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.3079183039397	46	0.0547454642477331
8DumKD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	62.1248116546335	45	0.0460083486625058
8DumKD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.3162799925331	46	0.0546664819961959
8DumKD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0454239737872325	46	1
8DumKD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.8722111051817	46	0.0238059047464326
8DumKD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	66.8609785578293	45	0.0188265807729999
8DumKD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.8727271969425	46	0.0238035467661946
8DumKD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0671982742466637	46	1
8DumKD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.6732251089405	46	0.134564216138911
8DumKD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	55.1639793896657	45	0.142528041255508
8DumKD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.6854398574071	46	0.134324326564186
8DumKD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.330665957086155	46	1
8eoi6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	23.0964862500884	17	0.146135813698439
8eoi6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	22.8895091875951	16	0.116720265224425
8eoi6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	23.099622563136	17	0.146035442968477
8eoi6H	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0280950865726635	17	1
8eoi6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	13.9682588910113	17	0.669347490782105
8eoi6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	13.9667192340443	16	0.601193282475339
8eoi6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	13.9704909213956	17	0.669189668929019
8eoi6H	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0267567378268808	17	1
8eoi6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	21.3283223955382	15	0.126663213335607
8eoi6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	21.3508491396493	14	0.0929736465917897
8eoi6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	21.3522198080102	15	0.125948203665216
8eoi6H	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.142299897829247	15	0.999999999999835
8fymme	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	59.9314795307931	52	0.210113587864012
8fymme	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.8974247627254	51	0.184176406150384
8fymme	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.9350226232718	52	0.210022530992511
8fymme	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0920808117094588	52	1
8fymme	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.0775447278355	52	0.159830506913323
8fymme	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.6933853317563	51	0.18905056874763
8fymme	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.081491218052	52	0.159746927788247
8fymme	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.192408161868232	52	1
8fymme	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.624409752962	51	0.488499787258041
8fymme	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	48.0362590624081	50	0.552529987734498
8fymme	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.6462633397943	51	0.487633732291485
8fymme	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.551093955216476	51	1
8IPZPp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	Maximum likelihood	80.0404836993662	48	0.00253202490238381
8IPZPp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	MR Egger	75.6406635672177	47	0.00506961868777972
8IPZPp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	Inverse variance weighted	80.0670109251227	48	0.00251686117382996
8IPZPp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int_imputed.txt_snps.txt	Unweighted regression	0.051990425014121	48	1
8IPZPp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	Maximum likelihood	65.8017871499563	48	0.0448210597317986
8IPZPp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	MR Egger	64.018802543205	47	0.049846802872884
8IPZPp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	Inverse variance weighted	65.8161581149929	48	0.044708704736089
8IPZPp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0571272434007919	48	1
8IPZPp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	Maximum likelihood	57.2435546390699	46	0.123709514686939
8IPZPp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	MR Egger	57.2550077046426	45	0.103996113671382
8IPZPp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	Inverse variance weighted	57.2555761213398	46	0.123488253801965
8IPZPp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int_imputed.txt_snps.txt	Unweighted regression	0.306713034545555	46	1
8zeOQS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	68.9698880793726	52	0.0576263699082659
8zeOQS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	MR Egger	68.9763120364175	51	0.0474812661478282
8zeOQS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	68.9773379519934	52	0.0575564874890384
8zeOQS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0687816399223425	52	1
8zeOQS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	71.7850664081387	52	0.0358532475035622
8zeOQS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	MR Egger	71.0592294623833	51	0.0331027801711117
8zeOQS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	71.8076158302565	52	0.0357126782167921
8zeOQS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.10900423047632	52	1
8zeOQS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	71.7714098985644	51	0.0291468191103151
8zeOQS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	MR Egger	71.6684734052346	50	0.0238762772915802
8zeOQS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	71.7720444284841	51	0.0291434886169241
8zeOQS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.459902313831173	51	1
92Pkkj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	Maximum likelihood	42.7494771727286	34	0.144347847825776
92Pkkj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	MR Egger	41.926930870761	33	0.137105747591112
92Pkkj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	Inverse variance weighted	43.0928065313561	34	0.136402184439838
92Pkkj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int_imputed.txt_snps.txt	Unweighted regression	0.0187353849559	34	1
92Pkkj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	Maximum likelihood	40.0798048851769	34	0.218508336597286
92Pkkj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	MR Egger	39.1467945587024	33	0.21326469866263
92Pkkj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	Inverse variance weighted	40.2379714958282	34	0.213483747056918
92Pkkj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int_imputed.txt_snps.txt	Unweighted regression	0.0240997143172792	34	1
92Pkkj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	Maximum likelihood	28.1716803209805	34	0.748442591086797
92Pkkj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	MR Egger	27.5998584671313	33	0.732875041365871
92Pkkj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	Inverse variance weighted	28.2284439917723	34	0.745951581487303
92Pkkj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int_imputed.txt_snps.txt	Unweighted regression	0.0823489674316713	34	1
96yzsN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	53.3143600884144	45	0.184880138426141
96yzsN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	MR Egger	50.9346927171191	44	0.21950035206948
96yzsN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	53.3145285300024	45	0.18487590913943
96yzsN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0711662530800472	45	1
96yzsN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.7616841718477	45	0.199129067148478
96yzsN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	MR Egger	51.4621615312689	44	0.20477773313968
96yzsN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.7624582528318	45	0.199108588330201
96yzsN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0821657721368541	45	1
96yzsN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.532456524577	42	0.0556224893650287
96yzsN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	MR Egger	57.5422198379401	41	0.0447564982966382
96yzsN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.578429404208	42	0.0551670084192831
96yzsN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.584422217608593	42	1
99Wp1h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	62.6263492320398	46	0.0518053954667264
99Wp1h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	62.6149581750671	45	0.0421299114323258
99Wp1h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	62.6264641241713	46	0.051804359496586
99Wp1h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0432593057046788	46	1
99Wp1h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	58.4911068460989	46	0.102348297863435
99Wp1h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	58.1464436630836	45	0.0903247507476419
99Wp1h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	58.4912772624287	46	0.102345594875337
99Wp1h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0619137634743438	46	1
99Wp1h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	59.0175044784571	45	0.0784135798661186
99Wp1h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	55.8670640500738	44	0.108214410044858
99Wp1h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	59.034824297341	45	0.0781905464213608
99Wp1h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.422953648045223	45	1
9c0Itn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	Maximum likelihood	39.5119909310013	20	0.0057546572460888
9c0Itn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	MR Egger	36.4583509893968	19	0.00926734596089271
9c0Itn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	Inverse variance weighted	39.5833217100454	20	0.00563726414173707
9c0Itn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int_imputed.txt_snps.txt	Unweighted regression	0.0366916479596358	20	1
9c0Itn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	Maximum likelihood	35.0242155763056	20	0.0199756835988602
9c0Itn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	MR Egger	32.58695772634	19	0.0268130444903584
9c0Itn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	Inverse variance weighted	35.0553925572205	20	0.0198112349826483
9c0Itn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int_imputed.txt_snps.txt	Unweighted regression	0.0606864760799805	20	1
9c0Itn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	Maximum likelihood	26.8302335218822	19	0.108669965363922
9c0Itn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	MR Egger	22.4909362218372	18	0.210916305401005
9c0Itn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	Inverse variance weighted	26.844708132856	19	0.108322565412345
9c0Itn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int_imputed.txt_snps.txt	Unweighted regression	0.229213740239043	19	0.999999999999999
9IpPLJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	Maximum likelihood	74.397651778668	45	0.0037958568330666
9IpPLJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	MR Egger	74.3833382913512	44	0.00283599777096299
9IpPLJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	Inverse variance weighted	74.4136541140222	45	0.00378216485909287
9IpPLJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int_imputed.txt_snps.txt	Unweighted regression	0.0550358836468651	45	1
9IpPLJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	Maximum likelihood	71.343399384574	45	0.00744548521654276
9IpPLJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	MR Egger	71.1072965980904	44	0.00595244769998672
9IpPLJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	Inverse variance weighted	71.362623311799	45	0.00741473596077628
9IpPLJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int_imputed.txt_snps.txt	Unweighted regression	0.07732073192766	45	1
9IpPLJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	Maximum likelihood	50.8727573703732	43	0.191337319765003
9IpPLJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	MR Egger	41.7626843548351	42	0.481291393068761
9IpPLJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	Inverse variance weighted	50.8963813064314	43	0.190717694351128
9IpPLJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int_imputed.txt_snps.txt	Unweighted regression	0.325316977898766	43	1
9ls47b	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	73.3262564419389	41	0.00142388422571485
9ls47b	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	MR Egger	72.8656490655649	40	0.00114502513816175
9ls47b	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	73.3271743201649	41	0.00142356160356736
9ls47b	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0828761176363384	41	1
9ls47b	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	64.8286234149606	41	0.0102674408031284
9ls47b	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	MR Egger	64.825035535993	40	0.00777630431760714
9ls47b	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	64.8286330528237	41	0.0102674193215718
9ls47b	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.147312806534024	41	1
9ls47b	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	43.5617427538892	38	0.246689957482221
9ls47b	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	MR Egger	39.7241616851641	37	0.349615946610199
9ls47b	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	43.6754513713128	38	0.242954752171068
9ls47b	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.292505516736145	38	1
9Niqao	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	Maximum likelihood	45.0600157258959	54	0.801718626619075
9Niqao	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	MR Egger	44.482836812905	53	0.791184284430685
9Niqao	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	45.0787464298949	54	0.801151924493785
9Niqao	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0479021000557115	54	1
9Niqao	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	Maximum likelihood	36.9896827036013	54	0.962734084762571
9Niqao	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	MR Egger	36.3652992508117	53	0.96061900691257
9Niqao	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	37.0068163250405	54	0.962560679140926
9Niqao	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0504557808175482	54	1
9Niqao	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	Maximum likelihood	62.2068519268876	54	0.207152316266945
9Niqao	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	MR Egger	60.7262975020687	53	0.217443635700947
9Niqao	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	62.2069212031122	54	0.207150582855652
9Niqao	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.526119155361123	54	1
9roB9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	66.3018596250918	42	0.00979574167381999
9roB9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	MR Egger	65.6234662235749	41	0.00862973840448384
9roB9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	66.349256720997	42	0.0096959245775183
9roB9g	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0618294573214449	42	1
9roB9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	58.5025369113458	42	0.046664659408343
9roB9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	MR Egger	58.0232174496843	41	0.0409024150757671
9roB9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	58.5300123590013	42	0.0464301953294026
9roB9g	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0925943198930502	42	1
9roB9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	52.1195263598758	39	0.0779251164789558
9roB9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	MR Egger	51.5520197567389	38	0.0700831243047324
9roB9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	52.1474956544428	39	0.0775451443044895
9roB9g	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.363815860467645	39	1
9ZZhiO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	70.6166622031214	46	0.0112895380508322
9ZZhiO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	MR Egger	70.472774799558	45	0.00896779852971444
9ZZhiO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	70.659144641104	46	0.011190964651072
9ZZhiO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0636151365779022	46	1
9ZZhiO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	69.5126870125522	46	0.0141457879682523
9ZZhiO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	MR Egger	69.1376850681928	45	0.0118642848231204
9ZZhiO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	69.5467418746596	46	0.014048672726354
9ZZhiO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0942108555093356	46	1
9ZZhiO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	49.8157457866675	45	0.287633576884467
9ZZhiO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	MR Egger	49.620716420045	44	0.259197123492205
9ZZhiO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	49.8157852229189	45	0.287632253569615
9ZZhiO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.374180222321325	45	1
A16cMQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.9465700879892	52	0.0292103077217582
A16cMQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	72.6327525965291	51	0.0249232903693336
A16cMQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.9842592155994	52	0.0290142071186473
A16cMQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0883587367570381	52	1
A16cMQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.4544354136457	52	0.0222165468073611
A16cMQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	74.4325456985398	51	0.0178083701458866
A16cMQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.460000281649	52	0.0221937685759791
A16cMQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.125517630472796	52	1
A16cMQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.5409897515382	51	0.651180951058774
A16cMQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	46.7215371448312	50	0.605727008006961
A16cMQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.7312176426683	51	0.643762860895232
A16cMQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.479470228814172	51	1
a8jHpu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.8691488929353	28	0.0830506141716799
a8jHpu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	34.3936745432326	27	0.15489944662373
a8jHpu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.8732773557554	28	0.0829827756030227
a8jHpu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0391857277623186	28	1
a8jHpu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	31.3653420393032	28	0.301098719277423
a8jHpu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	28.656970303045	27	0.377726560323693
a8jHpu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	31.3751342294332	28	0.300677070821937
a8jHpu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0407391437330747	28	1
a8jHpu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.4598185304576	25	0.492949306504934
a8jHpu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	24.4601568646927	24	0.435551700974891
a8jHpu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	24.4981512130762	25	0.490761292215392
a8jHpu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0995487510149824	25	1
a8uTTG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.6695019744564	54	0.375733693822481
a8uTTG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	56.4097239923393	53	0.348709880775261
a8uTTG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.7717693608241	54	0.372129187198858
a8uTTG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0634178215102581	54	1
a8uTTG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.7265643100635	54	0.171489642204187
a8uTTG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	62.6441681801277	53	0.171272002452669
a8uTTG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.8324534601906	54	0.169179764203908
a8uTTG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.106542487020154	54	1
a8uTTG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.1251751575674	54	0.395169051146438
a8uTTG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	56.1260003383744	53	0.358544943836565
a8uTTG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.1272055485717	54	0.395095801071024
a8uTTG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.465899779789046	54	1
AixCmS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	73.4528230606664	54	0.0402777670604242
AixCmS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	70.375020118444	53	0.0553320046289926
AixCmS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	73.484990170383	54	0.0400594407555302
AixCmS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0574109001459566	54	1
AixCmS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	69.123975941353	54	0.0806222932560921
AixCmS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	66.8662789743632	53	0.0954256194903326
AixCmS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	69.1918133888589	54	0.0797972413721483
AixCmS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0834522726105147	54	1
AixCmS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	60.1421523451331	53	0.233030762322463
AixCmS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	55.3199976935399	52	0.350502918421927
AixCmS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	60.1513300046165	53	0.232780380831715
AixCmS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.445718446600019	53	1
AM3sra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	66.2617456942857	43	0.0128825006503046
AM3sra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	MR Egger	63.5912801738782	42	0.017341785608096
AM3sra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	66.2831321972188	43	0.0128249839461684
AM3sra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0647166568017096	43	1
AM3sra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	64.250173300832	43	0.0194662798647139
AM3sra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	MR Egger	63.394079006574	42	0.0180569213370845
AM3sra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	64.2900351125218	43	0.0193107290524767
AM3sra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.106145636863241	43	1
AM3sra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	55.294045512874	41	0.0671982412938742
AM3sra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	MR Egger	47.2664845966236	40	0.200057464622577
AM3sra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	55.3280834311617	41	0.0667981656420789
AM3sra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.357700075721081	41	1
Aus8mK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	64.6385365342468	51	0.0949921230878077
Aus8mK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	MR Egger	64.6321357245464	50	0.0798585475095614
Aus8mK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	64.6453487579058	51	0.0948947804830373
Aus8mK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0711361199646715	51	1
Aus8mK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	52.9616062494244	51	0.398336590215274
Aus8mK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	MR Egger	51.9081109747635	50	0.399377959970251
Aus8mK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	52.9616623790373	51	0.398334500900806
Aus8mK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0908189837308826	51	1
Aus8mK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	65.9644650113621	51	0.0775081489250343
Aus8mK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	MR Egger	65.6616323914652	50	0.0677977954454706
Aus8mK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	65.9780984620178	51	0.0773431236871201
Aus8mK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.895208964991405	51	1
b9liN2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	58.9053884719021	35	0.00694056069615325
b9liN2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	MR Egger	58.8472456074835	34	0.00514460984231291
b9liN2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	58.9279318955786	35	0.00690360486689312
b9liN2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0536421184003178	35	1
b9liN2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	56.2583329151433	35	0.0128043908352891
b9liN2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	MR Egger	56.2349398235402	34	0.0096023579614208
b9liN2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	56.2759607151069	35	0.0127535195998462
b9liN2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0910740397241222	35	1
b9liN2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	30.0969260152776	34	0.659461725499419
b9liN2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	MR Egger	27.9329493625704	33	0.717545702578277
b9liN2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	30.2035464456018	34	0.65431751916174
b9liN2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.242753500467448	34	1
bH42gz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	61.8047953957742	36	0.00473849310097966
bH42gz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	MR Egger	60.8049379004351	35	0.00439522048427972
bH42gz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	61.8305404074982	36	0.00470922034083394
bH42gz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0614963339028461	36	1
bH42gz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	61.0760764146284	36	0.00564108029731125
bH42gz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	MR Egger	60.4128879900175	35	0.00483536062835163
bH42gz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	61.1134309342767	36	0.00559116366738397
bH42gz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0990919463845191	36	1
bH42gz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	31.4272923534468	34	0.594349274465295
bH42gz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	MR Egger	25.5528020410968	33	0.81927766973415
bH42gz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	31.5181022688115	34	0.589854215392226
bH42gz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.178936406476051	34	1
Bja4mG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	Maximum likelihood	63.5968648048191	42	0.0173219111480433
Bja4mG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	MR Egger	62.3036999591361	41	0.0175396264285995
Bja4mG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	Inverse variance weighted	63.617937143143	42	0.0172471045636714
Bja4mG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int_imputed.txt_snps.txt	Unweighted regression	0.0460741631253847	42	1
Bja4mG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	Maximum likelihood	56.620608838745	42	0.0653399330882921
Bja4mG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	MR Egger	56.5575142631881	41	0.0536356994261772
Bja4mG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	Inverse variance weighted	56.6214087598029	42	0.0653308182531253
Bja4mG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int_imputed.txt_snps.txt	Unweighted regression	0.0666625993020649	42	1
Bja4mG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	Maximum likelihood	41.5110129123807	40	0.404681693358112
Bja4mG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	MR Egger	39.941703148766	39	0.428102665301837
Bja4mG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	Inverse variance weighted	41.5693913835561	40	0.402220641088487
Bja4mG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int_imputed.txt_snps.txt	Unweighted regression	0.23752989746497	40	1
BN9YLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	93.8752219110124	69	0.02492397636841
BN9YLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	MR Egger	93.4409374050593	68	0.0220887514844483
BN9YLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	93.8999132395408	69	0.02482417742699
BN9YLQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.110165372173042	69	1
BN9YLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	94.5778075540815	69	0.0222183945097884
BN9YLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	MR Egger	94.5453087987381	68	0.0183593455392805
BN9YLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	94.6533208546374	69	0.0219436685433543
BN9YLQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.190478377612057	69	1
BN9YLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	89.1221422828038	66	0.0305474021220217
BN9YLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	MR Egger	88.5266016122905	65	0.0278385133376166
BN9YLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	89.2029778087652	66	0.0301512339544642
BN9YLQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.722082785261001	66	1
BoBYft	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.0755183279428	62	0.158666438942856
BoBYft	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	72.8752780073523	61	0.141896052904221
BoBYft	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.2576701242944	62	0.15514835543257
BoBYft	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0671078955693158	62	1
BoBYft	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.1913466585207	62	0.121278081879681
BoBYft	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	75.1625489433816	61	0.104940227025908
BoBYft	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.2766831575799	62	0.119925654559302
BoBYft	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.110586650924362	62	1
BoBYft	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.1218002796973	59	0.0887524487546481
BoBYft	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	74.4301365694454	58	0.0718708603740731
BoBYft	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.5332372684356	59	0.0836447497428047
BoBYft	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.569185348141605	59	1
bQ0SkB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.1683561012997	51	0.135879544503
bQ0SkB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	61.464978104268	50	0.1282844128627
bQ0SkB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.1747453706094	51	0.13575868024096
bQ0SkB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0823003459520045	51	1
bQ0SkB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	59.7956033174666	51	0.186597529456093
bQ0SkB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	59.755396951822	50	0.162515480034799
bQ0SkB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	59.7990197342592	51	0.186515931170443
bQ0SkB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.119517976762286	51	1
bQ0SkB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	61.1470736048273	51	0.156266062258594
bQ0SkB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	61.1072925319503	50	0.134946905361102
bQ0SkB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	61.184117287147	51	0.155489043863968
bQ0SkB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.917331706451362	51	1
btcJnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.1194055376873	29	0.14319458364763
btcJnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	MR Egger	36.127348584664	28	0.139383513890543
btcJnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.1194134932208	29	0.143194383429327
btcJnJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0318224655493331	29	1
btcJnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.4069926965985	29	0.22467402214696
btcJnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	MR Egger	33.5005955652206	28	0.217800472205419
btcJnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.4179679269179	29	0.224289340294084
btcJnJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0496782243361346	29	1
btcJnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.0312898921884	29	0.121642028134944
btcJnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	MR Egger	38.11512444013	28	0.0962404893114586
btcJnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.1154800562237	29	0.119789691036388
btcJnJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int_imputed.txt_snps.txt	Unweighted regression	0.424048419858903	29	1
bTouFk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	58.850569146879	50	0.183145592071812
bTouFk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	MR Egger	58.8365529936036	49	0.158571757981176
bTouFk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	58.8724583721554	50	0.182625459830947
bTouFk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.106676282817289	50	1
bTouFk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6910413015279	50	0.163924237039537
bTouFk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	MR Egger	59.2486383379559	49	0.149844528541974
bTouFk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.6910587144927	50	0.163923854662692
bTouFk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.124816549231989	50	1
bTouFk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	63.8330321798543	49	0.0756224979294529
bTouFk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	MR Egger	62.4455468997046	48	0.0786038893865053
bTouFk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	63.9754387071346	49	0.0739192445760129
bTouFk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.961934506251107	49	1
bUm7qh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	76.6053849792196	48	0.00540809564405131
bUm7qh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	76.4221638900225	47	0.0042712505122118
bUm7qh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	76.6151520193942	48	0.00539673400676367
bUm7qh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0653734173481606	48	1
bUm7qh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	69.6822921851715	48	0.022068761766361
bUm7qh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	68.3500119251133	47	0.0226035726167853
bUm7qh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	69.6926815332326	48	0.0220251615159302
bUm7qh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0959476541851064	48	1
bUm7qh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.2723512199647	48	0.0808064467668393
bUm7qh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	62.2085693640947	47	0.0677512429028228
bUm7qh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.4081926193355	48	0.0790747037047831
bUm7qh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.512634557744009	48	1
BVaOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	50.2220676329654	32	0.0212188735493456
BVaOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	MR Egger	48.7443336574703	31	0.0222981555976644
BVaOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	50.3362465451504	32	0.0206849806575018
BVaOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0298508572253113	32	1
BVaOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	44.681683605346	32	0.0674656194054983
BVaOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	MR Egger	44.7011387294516	31	0.0529845989222509
BVaOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	44.7527606038334	32	0.0665416615208903
BVaOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0459848465970774	32	1
BVaOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	40.5434778000004	32	0.142950361609293
BVaOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	MR Egger	39.6562704741198	31	0.136976707462042
BVaOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	40.716288330348	32	0.138833070481053
BVaOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.461915931954319	32	1
BZdGF7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.2825020219665	60	0.116447500131197
BZdGF7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	72.4257708001913	59	0.112508876754018
BZdGF7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.2984929717242	60	0.116197472103015
BZdGF7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0820134181128046	60	1
BZdGF7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	84.9551839166121	60	0.0187160857547274
BZdGF7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	83.3922182536278	59	0.0199960678728459
BZdGF7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	84.9821895904948	60	0.0186265886499207
BZdGF7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.153711140110094	60	1
BZdGF7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	81.9486070808574	57	0.016863930583423
BZdGF7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	81.9452249740699	56	0.0134922560647313
BZdGF7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	81.9532861841936	57	0.0168494929164464
BZdGF7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.522055839605905	57	1
c52600	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	83.2998713440223	43	0.000222138626518221
c52600	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	83.1841580230023	42	0.000158409205056818
c52600	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	83.3005934567889	43	0.000222096297087666
c52600	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.110919625478288	43	1
c52600	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.8868764428893	43	0.064205323176449
c52600	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	57.8602329254018	42	0.0524439973509141
c52600	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.8924167382419	43	0.064143737463337
c52600	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.121509173657759	43	1
c52600	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.3726716691828	41	0.109777323127393
c52600	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	50.4396384265918	40	0.12468366031315
c52600	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.3727750627968	41	0.109775501575962
c52600	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.395185178344283	41	1
caAbiz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	Maximum likelihood	44.6117864844808	50	0.688691978636001
caAbiz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	MR Egger	43.518732122719	49	0.694183279849764
caAbiz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	Inverse variance weighted	44.6365659121569	50	0.687747256846976
caAbiz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int_imputed.txt_snps.txt	Unweighted regression	0.0449177214197594	50	1
caAbiz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	Maximum likelihood	41.9160819722489	50	0.784921263946761
caAbiz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	MR Egger	41.1755612741095	49	0.778912195909698
caAbiz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	Inverse variance weighted	41.9351044958875	50	0.784295678244347
caAbiz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int_imputed.txt_snps.txt	Unweighted regression	0.0879963335947168	50	1
caAbiz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	Maximum likelihood	51.6935471436855	50	0.407483250152756
caAbiz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	MR Egger	51.137800935831	49	0.389717486693742
caAbiz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	Inverse variance weighted	51.7976010055692	50	0.403544580769307
caAbiz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int_imputed.txt_snps.txt	Unweighted regression	0.744924505790552	50	1
CbEqaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.086833839249	40	0.021488363931662
CbEqaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	59.8919126069028	39	0.0173132549818681
CbEqaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	60.0959944174748	40	0.0214480941127568
CbEqaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0581248684012266	40	1
CbEqaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.7220141033608	40	0.0283014291310423
CbEqaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	58.5802943024948	39	0.0227543546936757
CbEqaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	58.7295722323777	40	0.0282589354095948
CbEqaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0785303119266658	40	1
CbEqaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.8898960793265	39	0.0213471709426524
CbEqaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	57.5241718523912	38	0.0219505674326262
CbEqaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.0491456997527	39	0.0206542433613157
CbEqaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.450013654802246	39	1
ceCLEw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	Maximum likelihood	14.0492158767702	10	0.170758533779854
ceCLEw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	MR Egger	13.9567256732015	9	0.123872927926267
ceCLEw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	Inverse variance weighted	14.0585436219526	10	0.17033796288437
ceCLEw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int_imputed.txt_snps.txt	Unweighted regression	0.012077414470711	10	0.999999999999933
ceCLEw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	Maximum likelihood	12.5571129816627	10	0.249498445693668
ceCLEw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	MR Egger	12.564421349834	9	0.183326202424848
ceCLEw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	Inverse variance weighted	12.5765644000358	10	0.248319103272956
ceCLEw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int_imputed.txt_snps.txt	Unweighted regression	0.0178481006132666	10	0.999999999999532
ceCLEw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	Maximum likelihood	12.7328944913399	10	0.238991777474862
ceCLEw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	MR Egger	11.9866983073426	9	0.214060230368671
ceCLEw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	Inverse variance weighted	12.7629957894891	10	0.237226537316852
ceCLEw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int_imputed.txt_snps.txt	Unweighted regression	0.10363938149552	10	0.999999997017707
cjwOL2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	Maximum likelihood	9.39780048579626	10	0.494812175548993
cjwOL2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	MR Egger	7.96911966815467	9	0.537261195991395
cjwOL2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	Inverse variance weighted	9.4007172040935	10	0.494542473296415
cjwOL2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int_imputed.txt_snps.txt	Unweighted regression	0.00597977238039642	10	0.999999999999998
cjwOL2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	Maximum likelihood	10.6605321166918	10	0.38456979543667
cjwOL2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	MR Egger	10.2841029049192	9	0.327978937326377
cjwOL2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	Inverse variance weighted	10.6662508303163	10	0.38410421739117
cjwOL2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int_imputed.txt_snps.txt	Unweighted regression	0.0173794221341203	10	0.99999999999959
cjwOL2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	Maximum likelihood	3.21169929683383	10	0.975993807624525
cjwOL2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	MR Egger	2.86057302998476	9	0.969566973583382
cjwOL2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	Inverse variance weighted	3.21169930549737	10	0.975993807383611
cjwOL2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int_imputed.txt_snps.txt	Unweighted regression	0.0285018692686654	10	0.99999999999516
CPo1rt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.1087700500341	39	0.0653934524663992
CPo1rt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	MR Egger	49.8034661127097	38	0.0951856566511858
CPo1rt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.2948478113566	39	0.0632368435339065
CPo1rt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.029752735864189	39	1
CPo1rt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	58.5514241779107	39	0.0228897214688454
CPo1rt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	MR Egger	57.209675231072	38	0.0234317078843577
CPo1rt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	58.9370408815582	39	0.0211398887708691
CPo1rt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0468709109612523	39	1
CPo1rt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	44.315602697043	38	0.222621347607314
CPo1rt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	MR Egger	41.5324110375213	37	0.279736596163033
CPo1rt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	44.3179905155198	38	0.222547718294781
CPo1rt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.382714014265037	38	1
cpzFLN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	Maximum likelihood	70.1407531441788	45	0.00962015984931161
cpzFLN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	MR Egger	68.8856366701356	44	0.00963300094711855
cpzFLN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	Inverse variance weighted	70.1574839770656	45	0.00958627191557626
cpzFLN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int_imputed.txt_snps.txt	Unweighted regression	0.0378132692594154	45	1
cpzFLN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	Maximum likelihood	62.2126103216793	45	0.0452917785962302
cpzFLN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	MR Egger	61.5948368872209	44	0.0408869549796346
cpzFLN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	Inverse variance weighted	62.2424985653045	45	0.0450500517327937
cpzFLN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int_imputed.txt_snps.txt	Unweighted regression	0.0672458994471129	45	1
cpzFLN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	Maximum likelihood	60.5226151806365	45	0.0609005722090631
cpzFLN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	MR Egger	57.1795023728728	44	0.0877836612228372
cpzFLN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	Inverse variance weighted	60.6208735261007	45	0.0598821476028497
cpzFLN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int_imputed.txt_snps.txt	Unweighted regression	0.537733335700375	45	1
CuhDC5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	82.0362312095532	49	0.00215639496370538
CuhDC5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	MR Egger	81.2327416941589	48	0.00192880603166205
CuhDC5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	82.4972985801958	49	0.00194154888887607
CuhDC5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.0705733466749011	49	1
CuhDC5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	67.3105281967403	49	0.0422811421695802
CuhDC5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	MR Egger	65.8957576430845	48	0.0440907662492594
CuhDC5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	67.5524388815161	49	0.0405280130053225
CuhDC5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.087637715552724	49	1
CuhDC5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	54.6517384356885	48	0.236624683587527
CuhDC5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	MR Egger	44.0555922804087	47	0.595254152959293
CuhDC5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	54.8804701339102	48	0.230084726191198
CuhDC5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.294948286442535	48	1
Czudt0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	60.3313374330967	42	0.0331232600380542
Czudt0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	MR Egger	58.7597123666718	41	0.0355611892821881
Czudt0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	60.3633412578501	42	0.0329207940440582
Czudt0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0313401247290885	42	1
Czudt0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	52.2556178942802	42	0.13339976297627
Czudt0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	MR Egger	51.1501160203749	41	0.133044540612646
Czudt0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	52.2956324373448	42	0.13258891309965
Czudt0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0539380985180663	42	1
Czudt0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	55.8308527243619	42	0.0748753975800649
Czudt0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	MR Egger	52.5173692584737	41	0.107251540791445
Czudt0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	55.9612890697344	42	0.0732249702876629
Czudt0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.505093987910777	42	1
d71Yvr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	79.6165269840328	42	0.000406932844749994
d71Yvr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	MR Egger	79.2292986249867	41	0.000314546685862483
d71Yvr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	79.6167147810994	42	0.000406913007587847
d71Yvr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0808801113664377	42	1
d71Yvr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	84.2045147092643	42	0.00012020125759897
d71Yvr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	MR Egger	83.9666305859949	41	8.72635242929031e-05
d71Yvr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	84.2065423791711	42	0.000120135027308086
d71Yvr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.163571868559748	42	1
d71Yvr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	41.6141692916646	41	0.443894522194063
d71Yvr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	MR Egger	35.0984928447507	40	0.690309926129681
d71Yvr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	41.709282079047	41	0.439798385391621
d71Yvr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.322888355821727	41	1
DG1HIu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	55.844318506022	45	0.128946946417271
DG1HIu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	MR Egger	55.8839799208947	44	0.107928829503601
DG1HIu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	55.8887788614461	45	0.12809540048812
DG1HIu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0343832039369549	45	1
DG1HIu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	54.6952735884723	45	0.152497742361628
DG1HIu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	MR Egger	54.7299055433475	44	0.128823513406359
DG1HIu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	54.7683382137162	45	0.150910148617675
DG1HIu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0549598729711508	45	1
DG1HIu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	56.0723874385871	45	0.124624760960962
DG1HIu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	MR Egger	54.5250468143177	44	0.132840344667743
DG1HIu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	56.142478878358	45	0.123319290313917
DG1HIu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.431170263889499	45	1
Dq608h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.9975204428008	45	0.0665940409653874
Dq608h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	MR Egger	59.9283466190727	44	0.0551334985618595
Dq608h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.0549523138348	45	0.0659503263582982
Dq608h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0682457689605825	45	1
Dq608h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.6025675326361	45	0.0711648072850534
Dq608h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	MR Egger	59.5939551415341	44	0.0584533078761494
Dq608h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.6179968543092	45	0.0709814571990917
Dq608h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0938431620551489	45	1
Dq608h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.9306586072583	43	0.0756050775327595
Dq608h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	MR Egger	57.0095972536964	42	0.0610321062749029
Dq608h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	57.0313174370228	43	0.0743308113536793
Dq608h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.527723419120481	43	1
Dqym1a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	Maximum likelihood	69.4207072811527	45	0.0111869894019915
Dqym1a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	MR Egger	69.2861349807989	44	0.00884402806572171
Dqym1a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	69.4282456882211	45	0.0111694423363451
Dqym1a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0713556765784669	45	1
Dqym1a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	Maximum likelihood	57.5049387050652	45	0.100005752776337
Dqym1a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	MR Egger	57.5011205067021	44	0.0832886702995504
Dqym1a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	57.5106393308098	45	0.0999161904318825
Dqym1a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.109709593961156	45	1
Dqym1a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	Maximum likelihood	47.7978180159584	42	0.248997602128441
Dqym1a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	MR Egger	43.2518254688497	41	0.375380397776545
Dqym1a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	47.9319142397883	42	0.244768241368085
Dqym1a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.293350971751103	42	1
dY0KNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	94.1245786342114	47	5.43740652054615e-05
dY0KNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	91.4196301187969	46	7.73387117910982e-05
dY0KNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	94.1372223432364	47	5.4189091986496e-05
dY0KNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0870768467524044	47	1
dY0KNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	93.428965582655	47	6.55488333408295e-05
dY0KNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	88.9903034195825	46	0.000147327629125336
dY0KNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	93.4290607812426	47	6.55471617021598e-05
dY0KNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.163515886334368	47	1
dY0KNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	54.8527342095541	44	0.126460529304368
dY0KNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	54.2797464950021	43	0.116183446256883
dY0KNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	55.0457178955436	44	0.122815997054025
dY0KNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.409934436236157	44	1
DZ95Lx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	59.6889071376335	52	0.216411219004232
DZ95Lx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	59.6728975959565	51	0.189544949166891
DZ95Lx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	59.7021486969478	52	0.216064211146433
DZ95Lx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0501211620953235	52	1
DZ95Lx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	41.9487191969945	52	0.839121730628947
DZ95Lx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	41.926007713015	51	0.81352544744522
DZ95Lx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	41.9536278976292	52	0.838986036128502
DZ95Lx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0593997561197772	52	1
DZ95Lx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	69.8220765088913	50	0.0334209923240625
DZ95Lx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	MR Egger	69.5385566737643	49	0.0283696709035514
DZ95Lx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	69.8276918504394	50	0.0333875046446868
DZ95Lx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.553566808960583	50	1
E948Xc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	66.2064250360619	58	0.214773885739669
E948Xc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	MR Egger	65.8131052692328	57	0.198198168777098
E948Xc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	66.2097151869973	58	0.214692262960056
E948Xc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0614137851036062	58	1
E948Xc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	59.4519558637054	58	0.42249166207294
E948Xc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	MR Egger	58.5191827928137	57	0.41941368671434
E948Xc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	59.4542403065624	58	0.422410082933254
E948Xc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0821795849030758	58	1
E948Xc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	80.7001069532799	56	0.0170142239189487
E948Xc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	MR Egger	79.9044960610727	55	0.015775132468999
E948Xc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	80.7135815681264	56	0.0169720537737067
E948Xc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.609030493543494	56	1
eb24Q7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	70.0600637829572	40	0.00229089453796607
eb24Q7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	69.9963534361155	39	0.00168052348421938
eb24Q7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	70.078900288046	40	0.00228044828254002
eb24Q7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0606888823567715	40	1
eb24Q7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	68.8216920271475	40	0.00308570201953352
eb24Q7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	68.7155936651664	39	0.00230514143629062
eb24Q7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	68.8218512003377	40	0.00308558493253423
eb24Q7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.116284522646451	40	1
eb24Q7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	39.5450265992456	38	0.400832774023904
eb24Q7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	34.8222146209347	37	0.571551564074572
eb24Q7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	39.676537455159	38	0.395179276619326
eb24Q7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.29715450947186	38	1
eGRuZy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	67.8701003003294	58	0.17614179124181
eGRuZy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	67.0814433250774	57	0.169716099641332
eGRuZy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	67.8886326621856	58	0.175741145264348
eGRuZy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0867911798150838	58	1
eGRuZy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.4370557948988	58	0.837588717053415
eGRuZy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	46.48270997382	57	0.838816870427802
eGRuZy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.4499622644052	58	0.837251802209386
eGRuZy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0773951564589564	58	1
eGRuZy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	80.9355384280846	58	0.0250002327953567
eGRuZy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	80.6978005350603	57	0.02114571134161
eGRuZy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	80.9355384280846	58	0.0250002327953567
eGRuZy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	1.11738779535057	58	1
EhLDhT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.4012379445657	50	0.344922700757416
EhLDhT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	49.690103558859	49	0.445627467650385
EhLDhT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.4528352970046	50	0.343107586148459
EhLDhT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0443888024369323	50	1
EhLDhT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	51.6717466311267	50	0.408310317438001
EhLDhT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	45.9771327298134	49	0.596427701631549
EhLDhT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	51.7057712913422	50	0.407019772309522
EhLDhT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0648180667884135	50	1
EhLDhT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	53.3366128220471	50	0.347202798512365
EhLDhT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	52.9006199892561	49	0.325994332083645
EhLDhT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	53.5153575427812	50	0.340914546207713
EhLDhT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.765986547023484	50	1
eK0otG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	61.530126144076	51	0.148368910503516
eK0otG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	61.5575555810886	50	0.126601890288551
eK0otG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	61.5575834272778	51	0.147814495293502
eK0otG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0533881434192481	51	1
eK0otG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	50.361671322776	51	0.498934740719298
eK0otG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	49.9922252097474	50	0.473707629696419
eK0otG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	50.3692365528719	51	0.498633727220924
eK0otG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0779239528588577	51	1
eK0otG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	62.8676269195636	51	0.123131673409345
eK0otG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	62.8008591649875	50	0.105624451573246
eK0otG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	62.8851190660619	51	0.122825063430378
eK0otG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.758568681686197	51	1
eRChDn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	45.5183412989195	38	0.187620670662017
eRChDn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	MR Egger	41.9464667975751	37	0.265004472224636
eRChDn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	45.5290785685308	38	0.187326964830576
eRChDn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0263127821120362	38	1
eRChDn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	44.1057291030443	38	0.229157306116874
eRChDn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	MR Egger	42.6580184467576	37	0.240850697593631
eRChDn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	44.1146738374823	38	0.22887614794541
eRChDn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0378554076755869	38	1
eRChDn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	35.3922961152768	38	0.590660211923113
eRChDn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	MR Egger	35.442175085734	37	0.542140919575773
eRChDn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	35.4992425207407	38	0.585666073073859
eRChDn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.221721225282014	38	1
eTwEXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	Maximum likelihood	19.7947381740905	14	0.136746824023797
eTwEXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	MR Egger	19.5491489348964	13	0.107036394842827
eTwEXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	Inverse variance weighted	19.7947381740905	14	0.136746824023797
eTwEXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int_imputed.txt_snps.txt	Unweighted regression	0.0130046969881141	14	1
eTwEXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	Maximum likelihood	17.6176502346764	14	0.22475352801329
eTwEXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	MR Egger	17.5133343199189	13	0.17688695215672
eTwEXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	Inverse variance weighted	17.6176893530489	14	0.224751631740912
eTwEXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int_imputed.txt_snps.txt	Unweighted regression	0.0221363517119216	14	1
eTwEXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	Maximum likelihood	21.1282055157241	13	0.0704312727009515
eTwEXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	MR Egger	20.563689765401	12	0.0571463619083207
eTwEXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	Inverse variance weighted	21.1590699096372	13	0.0698414113921553
eTwEXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int_imputed.txt_snps.txt	Unweighted regression	0.176900391439138	13	0.999999999929508
eZdIEv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	Maximum likelihood	63.0058135292119	36	0.00353953527021615
eZdIEv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	MR Egger	62.9175057357749	35	0.00260222015209495
eZdIEv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	63.0190012844469	36	0.00352811081738761
eZdIEv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0643297853162977	36	1
eZdIEv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	Maximum likelihood	58.703607518863	36	0.00980922029658421
eZdIEv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	MR Egger	58.7229170684905	35	0.00724652044986584
eZdIEv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	58.723310243576	36	0.00976516553582686
eZdIEv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.106738362594954	36	1
eZdIEv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	Maximum likelihood	44.4919079358858	34	0.107492108992881
eZdIEv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	MR Egger	38.6460316422006	33	0.229663781524971
eZdIEv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	44.6291973959012	34	0.10494222904432
eZdIEv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.356969245915809	34	1
f6VX1D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	79.2644933060171	61	0.0580326773806711
f6VX1D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	79.2315847302877	60	0.0488382971671938
f6VX1D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	79.2764357877164	61	0.0579272839582649
f6VX1D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0668378658191447	61	1
f6VX1D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	83.9632284685091	61	0.027276649321437
f6VX1D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	82.7372430704793	60	0.027512410925235
f6VX1D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	83.9632284685091	61	0.0272766493214369
f6VX1D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.119116279528592	61	1
f6VX1D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.1820837845939	59	0.0562141851872401
f6VX1D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	77.2611707005332	58	0.0462797351433358
f6VX1D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.2629259458469	59	0.0555129989319189
f6VX1D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.817772999239937	59	1
fBKD1N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	122.431817770701	73	0.000259473729408183
fBKD1N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	MR Egger	121.296220308242	72	0.000250906353845745
fBKD1N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	122.471507394401	73	0.000257219941588603
fBKD1N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.151303823736524	73	1
fBKD1N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	109.390936631742	73	0.00375570753733183
fBKD1N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	MR Egger	109.435024313387	72	0.00294609566443433
fBKD1N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	109.440582481127	73	0.0037205985110313
fBKD1N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.226258213204181	73	1
fBKD1N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	78.6004452927234	68	0.178231597510462
fBKD1N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	MR Egger	74.26929887297	67	0.253432330458305
fBKD1N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	78.6263966775222	68	0.177705388233814
fBKD1N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.519094872483069	68	1
fEu0y9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	73.1058614809282	43	0.00282322422446491
fEu0y9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	MR Egger	73.0603517103991	42	0.00209495091505505
fEu0y9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	73.1254901030832	43	0.00281029883181267
fEu0y9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0823428854554649	43	1
fEu0y9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	72.2555650900991	43	0.00343985228508111
fEu0y9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	MR Egger	72.0851887055169	42	0.00264274924536004
fEu0y9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	72.2623416289407	43	0.00343447379403398
fEu0y9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.125435041054737	43	1
fEu0y9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	37.2209818664686	42	0.680502774638036
fEu0y9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	MR Egger	34.4339721197777	41	0.755890426771933
fEu0y9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	37.2858366043719	42	0.677761000834381
fEu0y9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.239225973094082	42	1
fiNVXZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	60.3353475510656	37	0.00904470204467045
fiNVXZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	MR Egger	59.6875854467637	36	0.00781926023163318
fiNVXZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	60.3634296634623	37	0.00898705749237115
fiNVXZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0509629802993095	37	1
fiNVXZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	55.1886164734648	37	0.0276015520309484
fiNVXZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	MR Egger	54.1174089723336	36	0.0267289355336162
fiNVXZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	55.2439720437695	37	0.0272892823917587
fiNVXZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.084396194376353	37	1
fiNVXZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	36.5713908462265	35	0.395668799692146
fiNVXZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	MR Egger	30.0948599213961	34	0.659561242240939
fiNVXZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	36.6002573022214	35	0.394380940583685
fiNVXZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.223632803239529	35	1
fLKUDF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	Maximum likelihood	28.3781962291068	28	0.44454775294091
fLKUDF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	MR Egger	28.0995884403501	27	0.40585252738107
fLKUDF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	Inverse variance weighted	28.3892645457839	28	0.443969875561565
fLKUDF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int_imputed.txt_snps.txt	Unweighted regression	0.0454818888273807	28	1
fLKUDF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	Maximum likelihood	24.5548397071066	28	0.651941229929242
fLKUDF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	MR Egger	24.5583390957069	27	0.59919827488553
fLKUDF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	Inverse variance weighted	24.5610793783666	28	0.651605285135359
fLKUDF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int_imputed.txt_snps.txt	Unweighted regression	0.0571860051863388	28	1
fLKUDF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	Maximum likelihood	43.4344198058977	27	0.0236343403182744
fLKUDF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	MR Egger	40.2071859336351	26	0.0372235555740775
fLKUDF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	Inverse variance weighted	43.4349317027435	27	0.0236314999081728
fLKUDF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int_imputed.txt_snps.txt	Unweighted regression	0.69095769121307	27	1
FuIYKf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	71.7574362534593	48	0.0147459044843788
FuIYKf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	MR Egger	71.0700382263344	47	0.0132393249036944
FuIYKf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	71.7674122120586	48	0.0147167730902808
FuIYKf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0512931139086547	48	1
FuIYKf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	66.1159192060667	48	0.0424198638488287
FuIYKf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	MR Egger	66.0459669411642	47	0.0347601135907943
FuIYKf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	66.1363770216927	48	0.0422674169335005
FuIYKf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0891282616190884	48	1
FuIYKf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	61.0733028743195	47	0.0815172346235301
FuIYKf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	MR Egger	56.3719889092582	46	0.140584533832773
FuIYKf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	61.0770461408089	47	0.0814683214390756
FuIYKf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.454855010716092	47	1
FzbwNX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	58.743246992565	52	0.242155168848215
FzbwNX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	58.7445681306735	51	0.212899853057832
FzbwNX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	58.7521129832871	52	0.241905034636992
FzbwNX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0496737877625994	52	1
FzbwNX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	47.4047869835081	52	0.654933872935922
FzbwNX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	47.2956478320411	51	0.621561450951582
FzbwNX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	47.4051382944043	52	0.654920383169643
FzbwNX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0649388188964314	52	1
FzbwNX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	59.9356575748763	51	0.183273067809867
FzbwNX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	59.6985759908797	50	0.163758841291217
FzbwNX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	59.935726751827	51	0.183271436196119
FzbwNX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.543745034758635	51	1
G4ZyMn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.3448753548093	55	0.0251587482433155
G4ZyMn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	77.32595945565	54	0.0203547504856138
G4ZyMn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.35087696758	55	0.025131915985334
G4ZyMn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0680481375737886	55	1
G4ZyMn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	79.1329768825412	55	0.0182025945787154
G4ZyMn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	79.011913450536	54	0.0148674610881322
G4ZyMn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	79.1386479628014	55	0.0181835919612134
G4ZyMn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0820153043633525	55	1
G4ZyMn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.1821438493755	53	0.231941007373977
G4ZyMn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	59.9043864095435	52	0.210810760310868
G4ZyMn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	60.2409433576703	53	0.230344769730485
G4ZyMn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.51632009220904	53	1
g8sWra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	80.6426480973419	48	0.00220809251260242
g8sWra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	MR Egger	79.6661688034167	47	0.0020531758499854
g8sWra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	80.6646319677544	48	0.00219703834187909
g8sWra	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0726310473480139	48	1
g8sWra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	73.1398162328531	48	0.0111724601594296
g8sWra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	MR Egger	72.401358658941	47	0.0100871096155165
g8sWra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	73.1698618868967	48	0.0111044166463653
g8sWra	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0961452619073821	48	1
g8sWra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	64.3517819207386	48	0.0574777763590157
g8sWra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	MR Egger	58.9884990028006	47	0.112721887217894
g8sWra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	64.4219320221281	48	0.0568021242375556
g8sWra	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.534796750217514	48	1
g9Zsdg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	57.9272752821745	38	0.0201753108983589
g9Zsdg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	MR Egger	57.6953592300218	37	0.0162606278391849
g9Zsdg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	57.9351162579551	38	0.0201420996840476
g9Zsdg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0626052293166057	38	1
g9Zsdg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	59.1421874477993	38	0.0155804493488634
g9Zsdg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	MR Egger	58.7724079026468	37	0.0128450337768343
g9Zsdg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	59.1465089851363	38	0.0155659571657705
g9Zsdg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.120847867302967	38	1
g9Zsdg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	39.8942667792181	35	0.261527984707054
g9Zsdg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	MR Egger	34.8550805819217	34	0.427153250932362
g9Zsdg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	39.9877474716477	35	0.258213778131225
g9Zsdg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.197490943976546	35	1
Gb685U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	87.7197083470493	56	0.00430636873624875
Gb685U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	84.7211448699604	55	0.00616879053483371
Gb685U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	87.7847236080944	56	0.00424882313805562
Gb685U	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.128991676658455	56	1
Gb685U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.0225054178672	56	0.053709181931435
Gb685U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	73.7430071104492	55	0.0465953700696725
Gb685U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.0246396563788	56	0.0536908842165608
Gb685U	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.167075993006678	56	1
Gb685U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	71.3010694713361	53	0.0475151601634049
Gb685U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	70.3108573716379	52	0.0461505292815361
Gb685U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	71.4941325952376	53	0.0460102501489254
Gb685U	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.746964575534953	53	1
GdOcFb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	54.2013727504521	56	0.543236859304308
GdOcFb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	54.1909650114027	55	0.505514466287178
GdOcFb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	54.2018793935091	56	0.54321747374237
GdOcFb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0544571378115285	56	1
GdOcFb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	50.6907052898798	56	0.675415428645801
GdOcFb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	50.6695814393542	55	0.640653999407743
GdOcFb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	50.6916409386282	56	0.675381464943819
GdOcFb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0835182511840387	56	1
GdOcFb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	66.9124688262494	54	0.11154482072263
GdOcFb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	66.4875392280584	53	0.100891873642652
GdOcFb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	66.9334926503059	54	0.111212085013094
GdOcFb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.461424091648309	54	1
gGxeBo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.3611682384662	52	0.31517543227814
gGxeBo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	53.5321166967433	51	0.37733524431284
gGxeBo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.3622023574902	52	0.315141316147355
gGxeBo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.061988841063597	52	1
gGxeBo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.6007907769189	52	0.275753367891683
gGxeBo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	56.3350632299579	51	0.282174414637657
gGxeBo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.601186952103	52	0.275741253143953
gGxeBo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.112933517781543	52	1
gGxeBo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.3315810742425	49	0.459858520569015
gGxeBo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	48.286868631279	48	0.461246105353268
gGxeBo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	49.3906428368566	49	0.457505371915515
gGxeBo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.469061291502449	49	1
GJwD35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	71.7618060985485	51	0.0291972680773511
GJwD35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	MR Egger	70.8486870607388	50	0.0277667226357879
GJwD35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	71.7697056775534	51	0.0291557658119005
GJwD35	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0618176063022904	51	1
GJwD35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	65.9413646944818	51	0.0777884263865221
GJwD35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	MR Egger	64.8085452547798	50	0.0776747703342988
GJwD35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	65.9641575825846	51	0.0775118735142329
GJwD35	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0686212941993827	51	1
GJwD35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	67.90402928875	49	0.038092475682484
GJwD35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	MR Egger	64.9974052477486	48	0.0515095355047629
GJwD35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	67.9506754300974	49	0.0377791064884892
GJwD35	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.453377714380584	49	1
GQjrH4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	Maximum likelihood	31.8936777891116	25	0.161111602889603
GQjrH4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	MR Egger	29.0518819721039	24	0.218184395861563
GQjrH4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	Inverse variance weighted	31.9025358027865	25	0.160851617931128
GQjrH4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int_imputed.txt_snps.txt	Unweighted regression	0.037602954508664	25	1
GQjrH4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	Maximum likelihood	19.0117931440845	25	0.79655473674782
GQjrH4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	MR Egger	18.9309020374563	24	0.755664522462751
GQjrH4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	Inverse variance weighted	19.0118665637418	25	0.796551212046424
GQjrH4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int_imputed.txt_snps.txt	Unweighted regression	0.0398408083669332	25	1
GQjrH4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	Maximum likelihood	25.4128434357012	23	0.329356376609161
GQjrH4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	MR Egger	24.6003654430184	22	0.316564553191924
GQjrH4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	Inverse variance weighted	25.4168255363751	23	0.329158042829307
GQjrH4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int_imputed.txt_snps.txt	Unweighted regression	0.198561515621026	23	1
GRNUGu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	76.2761296041633	55	0.0303601450456222
GRNUGu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	76.2692942424791	54	0.0246560120959021
GRNUGu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	76.2823251430546	55	0.0303274556706218
GRNUGu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0704266550876848	55	1
GRNUGu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.2502871470054	55	0.0255849988039212
GRNUGu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	76.1759878835423	54	0.0250720502977731
GRNUGu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.2605636046386	55	0.0255383818481337
GRNUGu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.105627449134462	55	1
GRNUGu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	51.8150170942269	54	0.55911679047185
GRNUGu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	51.8971408713081	53	0.517128749768287
GRNUGu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	51.9132192037684	54	0.555287820089373
GRNUGu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.440895791681938	54	1
HgMAXW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	115.224030532821	79	0.00490440779812497
HgMAXW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	MR Egger	113.629022316695	78	0.00526036326977428
HgMAXW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	115.263137486508	79	0.00487002606191273
HgMAXW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.157196214891645	79	1
HgMAXW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	117.999419168109	79	0.00294892099922714
HgMAXW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	MR Egger	118.023026121099	78	0.00233102242548166
HgMAXW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	118.077481338468	79	0.00290623564507144
HgMAXW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.252657148845625	79	1
HgMAXW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	71.7185931542311	74	0.553502918253055
HgMAXW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	MR Egger	69.6558331966281	73	0.589276966951911
HgMAXW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	71.724642415741	74	0.553302328508791
HgMAXW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.613854856519185	74	1
HHg5WS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	54.6909360594396	30	0.00384689794402358
HHg5WS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	MR Egger	54.3015376041909	29	0.0029864691992715
HHg5WS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	54.880361750775	30	0.00366222673037432
HHg5WS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0643574115307689	30	1
HHg5WS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	50.6206688230411	30	0.0106811582254799
HHg5WS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	MR Egger	49.357787094352	29	0.0105815879695484
HHg5WS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	50.7119927371923	30	0.0104474083556024
HHg5WS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0830402000612417	30	1
HHg5WS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	44.6695432836423	27	0.01761449565074
HHg5WS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	MR Egger	44.7261404645594	26	0.012611797491947
HHg5WS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	44.7623103259722	27	0.0172243745603725
HHg5WS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.284530966416612	27	1
hHl3FO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	Maximum likelihood	68.3993975822644	45	0.0138107470325641
hHl3FO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	MR Egger	65.0012673083545	44	0.0213746989280212
hHl3FO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	Inverse variance weighted	68.3995423319381	45	0.0138103384945669
hHl3FO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int_imputed.txt_snps.txt	Unweighted regression	0.0681834498303581	45	1
hHl3FO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	Maximum likelihood	62.0642523064981	45	0.046508280167991
hHl3FO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	MR Egger	61.0841744315063	44	0.0448685980205071
hHl3FO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	Inverse variance weighted	62.0648196761002	45	0.0465035747733397
hHl3FO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int_imputed.txt_snps.txt	Unweighted regression	0.13819236220749	45	1
hHl3FO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	Maximum likelihood	68.504797018955	44	0.0104426660319187
hHl3FO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	MR Egger	68.4669051313841	43	0.00804694447834237
hHl3FO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	Inverse variance weighted	68.5150183433582	44	0.0104201450658837
hHl3FO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int_imputed.txt_snps.txt	Unweighted regression	0.420725707843744	44	1
hZL2xX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	Maximum likelihood	29.2025859243502	22	0.139167245255796
hZL2xX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	MR Egger	29.133834835939	21	0.110825269602251
hZL2xX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	Inverse variance weighted	29.2112246438089	22	0.138928457020106
hZL2xX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0298528453148183	22	1
hZL2xX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	Maximum likelihood	22.1169267800443	22	0.452928297011537
hZL2xX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	MR Egger	22.1068885660631	21	0.393372857397009
hZL2xX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	Inverse variance weighted	22.1179313121828	22	0.452868665120317
hZL2xX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0313585764951531	22	1
hZL2xX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.8753380889983	22	0.0189206568547778
hZL2xX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	MR Egger	37.61315770372	21	0.0143005703560283
hZL2xX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.8801346734259	22	0.018897288219466
hZL2xX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int_imputed.txt_snps.txt	Unweighted regression	0.527696687214128	22	0.999999999999991
HzstLF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	77.8594787727501	44	0.00124268566469044
HzstLF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	MR Egger	73.6345447160215	43	0.00249388371661384
HzstLF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	77.8616945022102	44	0.00124201736315949
HzstLF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0700790383815116	44	1
HzstLF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	75.0660945096613	44	0.00241901485612531
HzstLF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	MR Egger	70.6522345169188	43	0.0049592310830294
HzstLF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	75.0686038609693	44	0.00241759461338882
HzstLF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0783704012113233	44	1
HzstLF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	52.8020018599654	43	0.145348498190156
HzstLF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	MR Egger	49.7501619989454	42	0.192058924549499
HzstLF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	52.8133363520442	43	0.145105358103465
HzstLF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.365603216296797	43	1
IV5xNU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	66.323729467545	42	0.00974956765664329
IV5xNU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	MR Egger	65.3649560820122	41	0.00913391268994938
IV5xNU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	66.3508758638679	42	0.00969253126360496
IV5xNU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0434328079179524	42	1
IV5xNU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	58.0423406569718	42	0.0507462059877535
IV5xNU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	MR Egger	56.2638246124366	41	0.0565600470183528
IV5xNU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	58.0584806117057	42	0.0505980335961618
IV5xNU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0615179633159826	42	1
IV5xNU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	46.6279139913788	42	0.287846761139645
IV5xNU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	MR Egger	44.4056734009357	41	0.330197233190338
IV5xNU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	46.729184104746	42	0.284347673344628
IV5xNU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.383105294719735	42	1
iXPMwc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.0234938761052	23	0.00902141327518962
iXPMwc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	41.1750202626045	22	0.00785463081024388
iXPMwc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.0366316977096	23	0.00898965763174373
iXPMwc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0469371648938264	23	1
iXPMwc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.5222480261135	23	0.0286432213241781
iXPMwc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	36.4675898911926	22	0.0270395827781445
iXPMwc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.5249707140076	23	0.028624180877632
iXPMwc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0754337345947115	23	1
iXPMwc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	28.0124750470168	21	0.139797881061676
iXPMwc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	16.3762381762086	20	0.693025886530912
iXPMwc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	28.1037350619073	21	0.137233720689451
iXPMwc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.131089710661699	21	1
iz0afJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.4140798743947	18	0.0906601960360875
iz0afJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	MR Egger	26.3465970961257	17	0.0683731570486009
iz0afJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.4379153454291	18	0.0901586021926544
iz0afJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.016149447017515	18	1
iz0afJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.7834013765589	18	0.0831486450830212
iz0afJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	MR Egger	26.7421702373534	17	0.0619590432535451
iz0afJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.7932185552569	18	0.0829564460544644
iz0afJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.023278599082999	18	1
iz0afJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	Maximum likelihood	21.8420603637989	18	0.239072710725252
iz0afJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	MR Egger	20.7907372748357	17	0.235790838207513
iz0afJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	21.8948693260507	18	0.23668607145064
iz0afJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0896615036134468	18	1
j5axsu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	63.6060920956415	45	0.0351453872830273
j5axsu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	62.0116861027149	44	0.0378679060323599
j5axsu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	63.6537464874614	45	0.034836713959211
j5axsu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0627814540843326	45	1
j5axsu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	62.0412309775899	45	0.0466995502690689
j5axsu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	61.2468174909324	44	0.043565555389333
j5axsu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	62.0672939158152	45	0.046483059829946
j5axsu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.120470917652758	45	1
j5axsu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	55.0218167821042	43	0.103383828345869
j5axsu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	54.8608331013514	42	0.088141549874423
j5axsu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	55.0560868506057	43	0.102821095222063
j5axsu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.407162562818644	43	1
j7bfug	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.9643862378377	58	0.0174327823439804
j7bfug	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	82.9245533869669	57	0.0140824343492554
j7bfug	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.9798705699948	58	0.0173839378536739
j7bfug	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0567540444608151	58	1
j7bfug	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	83.0855013168504	58	0.0170539940696821
j7bfug	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	82.820057504839	57	0.0143590600924445
j7bfug	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	83.0860288076735	58	0.0170523606227957
j7bfug	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0558031477878642	58	1
j7bfug	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.0658906127504	58	0.761314012328961
j7bfug	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	50.1171813366931	57	0.728882609110691
j7bfug	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.1303320061407	58	0.759265281540064
j7bfug	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.333150164863052	58	1
J8dEqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	Maximum likelihood	72.0960809703366	42	0.00263594690575629
J8dEqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	MR Egger	72.1025288850854	41	0.0019215033975691
J8dEqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	Inverse variance weighted	72.1043204987061	42	0.00263081217472725
J8dEqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0744612978342273	42	1
J8dEqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	Maximum likelihood	64.8492229634348	42	0.013351770326846
J8dEqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	MR Egger	64.8666437450606	41	0.0101830184998065
J8dEqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	Inverse variance weighted	64.8671657267461	42	0.013301460351083
J8dEqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0920294881988864	42	1
J8dEqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	Maximum likelihood	53.1558071890237	41	0.0966567663642155
J8dEqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	MR Egger	46.0195797023969	40	0.237098013624731
J8dEqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	Inverse variance weighted	53.1774265615453	41	0.0963133590465447
J8dEqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int_imputed.txt_snps.txt	Unweighted regression	0.251933274797691	41	1
Jgsi9G	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.0769932814356	56	0.147608222884244
Jgsi9G	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	63.1043757838656	55	0.211680420613558
Jgsi9G	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.0884858048547	56	0.147386274359573
Jgsi9G	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0645426625218886	56	1
Jgsi9G	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.6581251821938	56	0.136694619456013
Jgsi9G	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	66.6597455475323	55	0.134752843198662
Jgsi9G	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.6590303204115	56	0.136678109873826
Jgsi9G	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0999289077279501	56	1
Jgsi9G	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.6503489194956	55	0.175161250418248
Jgsi9G	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	63.877051815115	54	0.168213645363118
Jgsi9G	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.7493191520535	55	0.172986381428534
Jgsi9G	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.732940063585002	55	1
jhHc6Y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	88.1069248033637	53	0.00175017463887236
jhHc6Y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	86.6912038993067	52	0.00180239605268449
jhHc6Y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	88.1497843533518	53	0.00173348949773041
jhHc6Y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.111848925982706	53	1
jhHc6Y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	87.1542256395184	53	0.00216251964533246
jhHc6Y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	86.3985481939428	52	0.00192458960610868
jhHc6Y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	87.166229845023	53	0.0021567981542578
jhHc6Y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.146552383599128	53	1
jhHc6Y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.298249774802	51	0.90539724554996
jhHc6Y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	38.4392407901655	50	0.883258134403236
jhHc6Y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.4458393371993	51	0.902382366897927
jhHc6Y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.391458525578808	51	1
jIPt1m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	48.60196346199	39	0.139384489934317
jIPt1m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	48.3178397045064	38	0.12186783486133
jIPt1m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	48.6023792607267	39	0.139375469242969
jIPt1m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.049135543049264	39	1
jIPt1m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	51.3555415898713	39	0.0889157614727011
jIPt1m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	49.9799440113126	38	0.0923578457347346
jIPt1m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	51.3618235960722	39	0.0888204570687911
jIPt1m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0721586219739568	39	1
jIPt1m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	59.8641984739595	38	0.0133224518065938
jIPt1m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	58.9450003809375	37	0.012363109152715
jIPt1m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.9417497289371	38	0.0130985863637378
jIPt1m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.424145085134225	38	1
jjp1v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	60.357098062408	36	0.00668652841881542
jjp1v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	MR Egger	60.3823804925085	35	0.00487128427785747
jjp1v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	60.3902277043138	36	0.0066346433054595
jjp1v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0493509645500877	36	1
jjp1v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	54.4198947266195	36	0.0250914019757176
jjp1v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	MR Egger	53.8769137669739	35	0.021649750469628
jjp1v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	54.4522481542087	36	0.024921677342541
jjp1v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0820974684865434	36	1
jjp1v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	27.2456834500644	34	0.787638416859672
jjp1v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	MR Egger	23.3918552594233	33	0.892083810620534
jjp1v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	27.3178675877896	34	0.784686454966915
jjp1v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.149821924533406	34	1
josFUR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	100.802493144494	64	0.00227992517282914
josFUR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	97.4797102830245	63	0.0034773931278265
josFUR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	100.850126203979	64	0.00225771441825056
josFUR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.144906946015835	64	1
josFUR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	103.134619172661	64	0.00140188959108267
josFUR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	102.13286685361	63	0.00132539609661706
josFUR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	103.14408552313	64	0.00139908459917749
josFUR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.214557991855012	64	1
josFUR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	84.9405437956647	59	0.0151329142505487
josFUR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	82.8556933282459	58	0.0177791268877667
josFUR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	85.1153985138374	59	0.0146567466875179
josFUR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.712784839372082	59	1
jPAemg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	79.5727879411372	50	0.00491239411180034
jPAemg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	79.5741540657562	49	0.0037351581165552
jPAemg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	79.5789695573978	50	0.00490591196854899
jPAemg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0732839399720929	50	1
jPAemg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.5980156086239	50	0.00744202194219807
jPAemg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	77.5973081829015	49	0.00572529693986306
jPAemg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.5992948438136	50	0.0074400510556088
jPAemg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.123512692784914	50	1
jPAemg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.4753924079914	49	0.125993628898573
jPAemg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.5813446759781	48	0.12195483908662
jPAemg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	60.5445076759506	49	0.124742326352117
jPAemg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.4087879213436	49	1
JVzPCN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	93.0865411650097	63	0.00817966377741818
JVzPCN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	MR Egger	92.7112950740119	62	0.00696911952054992
JVzPCN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	93.0892202975493	63	0.00817553877766016
JVzPCN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.105138538288573	63	1
JVzPCN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	87.0833581327996	63	0.02395100635015
JVzPCN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	MR Egger	87.0840744961893	62	0.0195484900272793
JVzPCN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	87.1063072592886	63	0.0238580889793855
JVzPCN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.140766323179285	63	1
JVzPCN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	87.587279735273	60	0.0115992726764453
JVzPCN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	MR Egger	85.7713727897706	59	0.0129885025511783
JVzPCN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	87.5948939331124	60	0.0115828531664177
JVzPCN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.732766100835721	60	1
jYrLn7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	Maximum likelihood	17.9975762011549	18	0.455812289653616
jYrLn7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	MR Egger	17.9299984676045	17	0.39326993339594
jYrLn7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	17.9976015510635	18	0.455810619433308
jYrLn7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0376548280126146	18	1
jYrLn7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	Maximum likelihood	19.1272975155857	18	0.384024205047444
jYrLn7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	MR Egger	18.3847433857614	17	0.364966689859462
jYrLn7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	19.1309961337916	18	0.383798795470041
jYrLn7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0557398773527546	18	1
jYrLn7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	Maximum likelihood	23.3923988877856	16	0.103640637453985
jYrLn7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	MR Egger	17.679357091746	15	0.279897683049463
jYrLn7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	23.3928318368238	16	0.103629930255529
jYrLn7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.588286879316404	16	0.999999998929492
JZ3cvz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	76.9850717918967	38	0.000186799674776191
JZ3cvz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	76.8443413898405	37	0.000130964847537904
JZ3cvz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	76.9873246272236	38	0.000186683554059783
JZ3cvz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.108794747581883	38	1
JZ3cvz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	61.3554067471628	37	0.00715576246686177
JZ3cvz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	61.0507473004207	36	0.00567516337491097
JZ3cvz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	61.3563347454108	37	0.00715422421611343
JZ3cvz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.128417868574709	37	1
JZ3cvz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.1434617965736	35	0.0985291095077354
JZ3cvz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	45.870492528828	34	0.0840435242136122
JZ3cvz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.1526896324164	35	0.0983698773396978
JZ3cvz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.543328553266258	35	1
kdxq73	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	48.2767690924237	23	0.00154188728592464
kdxq73	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	48.2535971907612	22	0.00100438389707797
kdxq73	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	48.3666527085771	23	0.00150144006516405
kdxq73	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0491113243261135	23	1
kdxq73	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.7174466465273	23	0.02130396691281
kdxq73	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	38.7061589713906	22	0.0152457228574212
kdxq73	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.7371793509234	23	0.0211986570020595
kdxq73	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0642834263121685	23	1
kdxq73	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	28.1248925881177	20	0.106475712237809
kdxq73	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	27.7950589599898	19	0.0874529109722465
kdxq73	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	28.2232469000145	20	0.10421908984368
kdxq73	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.281313907861528	20	0.999999999999999
KffQXv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	87.5882810354019	50	0.000803168224634316
KffQXv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	86.3638148955848	49	0.000785644310740846
KffQXv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	87.5882810354019	50	0.000803168224634316
KffQXv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0734714262053711	50	1
KffQXv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.9805787940125	50	0.00232902291711224
KffQXv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	80.1867391409335	49	0.00326375915380812
KffQXv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.9949362768224	50	0.0023215343794212
KffQXv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.109716220904818	50	1
KffQXv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	69.0945661678704	49	0.0307665448391783
KffQXv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	68.5047212379053	48	0.0275382199579044
KffQXv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	69.2631311840413	49	0.0298363324741783
KffQXv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.539523860208057	49	1
kmOA5d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	63.1391176286424	40	0.0112805721475077
kmOA5d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	MR Egger	63.0646577765301	39	0.00867767539771569
kmOA5d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	63.2141686076024	40	0.0110979278921616
kmOA5d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0461821415493533	40	1
kmOA5d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	58.070490419279	40	0.032184332425462
kmOA5d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	MR Egger	58.1560037758787	39	0.0248177428808779
kmOA5d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	58.1747861673429	40	0.0315327529610166
kmOA5d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0673243499078805	40	1
kmOA5d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	47.2896813110853	40	0.1994088839685
kmOA5d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	MR Egger	46.6230650616486	39	0.187545149793588
kmOA5d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	47.3720805988593	40	0.19711692924242
kmOA5d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.412361783036432	40	1
KtnxLn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	Maximum likelihood	74.2202163491336	41	0.00114046378436629
KtnxLn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	MR Egger	73.4818042150135	40	0.000979964556991306
KtnxLn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	Inverse variance weighted	74.2202618768701	41	0.00114045082059831
KtnxLn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int_imputed.txt_snps.txt	Unweighted regression	0.0866794851434839	41	1
KtnxLn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	Maximum likelihood	69.0849520887965	41	0.00393948132176927
KtnxLn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	MR Egger	69.0918264734206	40	0.00289288885486888
KtnxLn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	Inverse variance weighted	69.0955307648391	41	0.003929792042333
KtnxLn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int_imputed.txt_snps.txt	Unweighted regression	0.147338278432745	41	1
KtnxLn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	Maximum likelihood	43.6079111808789	39	0.281845759958671
KtnxLn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	MR Egger	33.4374246213412	38	0.680306059967599
KtnxLn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	Inverse variance weighted	43.7296243212139	39	0.277550391051347
KtnxLn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int_imputed.txt_snps.txt	Unweighted regression	0.309831866751801	39	1
KuEW13	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	66.2035892300128	53	0.105151392439889
KuEW13	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	64.8098817641072	52	0.109379508371573
KuEW13	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	66.2245224322715	53	0.10483258632545
KuEW13	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0622855403613029	53	1
KuEW13	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	71.1383215994303	53	0.0488163049989153
KuEW13	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	70.1150190442103	52	0.0476935290407591
KuEW13	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	71.1411112964797	53	0.0487937478714009
KuEW13	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.112421723693726	53	1
KuEW13	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	73.3973099453215	52	0.0269398953321794
KuEW13	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	68.6710417941785	51	0.0499853437105829
KuEW13	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	73.3994256583543	52	0.0269296166320039
KuEW13	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.714805114420996	52	1
KUmGnn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	78.5524868422528	39	0.000178604112717492
KUmGnn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	MR Egger	77.6375388424072	38	0.000155924342345543
KUmGnn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	78.6935725759104	39	0.000171820543524127
KUmGnn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0928762425949959	39	1
KUmGnn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	66.5688058626248	39	0.00386643271492734
KUmGnn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	MR Egger	64.3831993526447	38	0.00476776088547178
KUmGnn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	66.7055895765035	39	0.00374290066452416
KUmGnn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.125312719400963	39	1
KUmGnn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	51.4782969262054	38	0.0710166984773997
KUmGnn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	MR Egger	51.4798963062435	37	0.0572139862663322
KUmGnn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	51.4826310845195	38	0.0709615266632932
KUmGnn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.428433245289411	38	1
kxUV8T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.6176065193282	39	0.000394765185139062
kxUV8T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	75.503543042187	38	0.00028032539261621
kxUV8T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.6237603225644	39	0.000394119194712386
kxUV8T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0890085437916555	39	1
kxUV8T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.2790136770516	39	6.31192173813695e-05
kxUV8T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	81.9354649355346	38	4.61378654491188e-05
kxUV8T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.2796725143976	39	6.31074147159918e-05
kxUV8T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.235811001986071	39	1
kxUV8T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.3917973112092	36	0.214650968923198
kxUV8T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	41.3612200570844	35	0.212655337482275
kxUV8T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.4133040257889	36	0.213988702951704
kxUV8T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.423943376826529	36	1
L2hzbd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	69.6945408724406	50	0.0341895209569777
L2hzbd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	MR Egger	67.9453337209684	49	0.0378148780575703
L2hzbd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	69.7931525219097	50	0.0335939497205872
L2hzbd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0431804612427208	50	1
L2hzbd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	62.7506444486963	50	0.106414767335103
L2hzbd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	MR Egger	62.2510521158796	49	0.0968060309526656
L2hzbd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	62.8602611254309	50	0.104695559425343
L2hzbd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0622420424405306	50	1
L2hzbd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	64.871115351679	50	0.0769121178817067
L2hzbd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	MR Egger	55.8713471002447	49	0.232468213956304
L2hzbd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	64.9597950051874	50	0.0758418004377369
L2hzbd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.413321735276687	50	1
L3cATD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	103.1834609438	44	1.1696416627981e-06
L3cATD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	103.109603870847	43	7.56346413474578e-07
L3cATD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	103.186693361215	44	1.16849845919456e-06
L3cATD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0882001267482126	44	1
L3cATD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	83.8355056189467	44	0.000276529563086772
L3cATD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	83.820841064661	43	0.000193534598328847
L3cATD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	83.8358684218773	44	0.00027650350237209
L3cATD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.122278829791706	44	1
L3cATD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.0908927763256	41	0.0183277117903928
L3cATD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	62.0950233844835	40	0.014123392631795
L3cATD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.0970249500668	41	0.0183045626712811
L3cATD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.364640250291446	41	1
L9h0ZS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	80.851199793777	55	0.0131970992113832
L9h0ZS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	MR Egger	76.7848514948359	54	0.0224657299471053
L9h0ZS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	80.8526029030583	55	0.0131935795555002
L9h0ZS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.076298182681403	55	1
L9h0ZS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	73.1440251334452	55	0.0513772881968736
L9h0ZS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	MR Egger	68.6178627855856	54	0.0870000156197622
L9h0ZS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	73.1486532779722	55	0.0513387962678614
L9h0ZS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0944443854045801	55	1
L9h0ZS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	Maximum likelihood	60.8768854174068	52	0.186764197582674
L9h0ZS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	MR Egger	57.9309590064423	51	0.234904892883271
L9h0ZS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	60.8821757013939	52	0.186638879511273
L9h0ZS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.413790568304381	52	1
ldLkBF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	Maximum likelihood	85.3010687931966	70	0.10296770222279
ldLkBF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	MR Egger	84.4749197217777	69	0.0992569240743939
ldLkBF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	85.3464007920111	70	0.102366871445656
ldLkBF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0815046156707139	70	1
ldLkBF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	Maximum likelihood	84.0706289425126	70	0.120355802951579
ldLkBF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	MR Egger	84.1102213946257	69	0.104083361963682
ldLkBF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	84.1300866704722	70	0.11946668341146
ldLkBF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.107841318541532	70	1
ldLkBF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	Maximum likelihood	77.6615818721097	66	0.154343138238163
ldLkBF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	MR Egger	70.5413629923318	65	0.297724295207306
ldLkBF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	77.6809254763596	66	0.153984540574056
ldLkBF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.456311335837409	66	1
LoQQME	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.3754956447836	35	0.498078813548609
LoQQME	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	33.8662115976358	34	0.474191588812827
LoQQME	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.3793129253131	35	0.497894895084681
LoQQME	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0435274044571922	35	1
LoQQME	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	45.2108142527289	35	0.115731430469271
LoQQME	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	41.8825667603117	34	0.165984750206358
LoQQME	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	45.2133521907637	35	0.11568156207987
LoQQME	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.103021597393325	35	1
LoQQME	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	44.9456933770626	33	0.0803094078187372
LoQQME	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	MR Egger	44.7890653858292	32	0.0660738792118881
LoQQME	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	44.9514348314394	33	0.0802236056348897
LoQQME	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.344776388640779	33	1
lXNNtt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	68.9830558203196	58	0.153224135558217
lXNNtt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	MR Egger	68.4396964536353	57	0.142617510460487
lXNNtt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	68.98306597467	58	0.153223936972046
lXNNtt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0570905889822519	58	1
lXNNtt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	68.3211436186872	58	0.166574802120126
lXNNtt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	MR Egger	67.9765073741006	57	0.15147033096604
lXNNtt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	68.3211946257355	58	0.16657374185561
lXNNtt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.075683963726523	58	1
lXNNtt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	87.1975823704313	56	0.00479545594901382
lXNNtt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	MR Egger	81.8444442774381	55	0.0109082184498352
lXNNtt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	87.258327351872	56	0.00473601526176932
lXNNtt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.49402839742561	56	1
LYrhQf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.8118386352241	55	0.0460710677129499
LYrhQf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	72.7546845103816	54	0.0452758874449523
LYrhQf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.9139033732847	55	0.0453029309925451
LYrhQf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.115224140447613	55	1
LYrhQf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	73.1082111548215	55	0.0516759808841901
LYrhQf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	73.0546361666708	54	0.0430666643548471
LYrhQf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	73.1549587071977	55	0.051286393957501
LYrhQf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.154364772225031	55	1
LYrhQf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	62.5526443026839	52	0.149998248918778
LYrhQf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	62.5858062705717	51	0.128153549468367
LYrhQf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	62.8057670267552	52	0.14494721159999
LYrhQf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.685846565656407	52	1
MAuIx0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	74.342611645758	50	0.0143369592651504
MAuIx0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	MR Egger	68.8594727943531	49	0.0321064441941312
MAuIx0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	74.3430335368344	50	0.0143357758337935
MAuIx0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0663296369343513	50	1
MAuIx0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	61.1915762636971	50	0.133353682405237
MAuIx0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	MR Egger	57.7654941592592	49	0.182993428696206
MAuIx0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	61.1978134271199	50	0.133236354050191
MAuIx0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.060537136620072	50	1
MAuIx0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	65.4242382166296	48	0.0478611578941293
MAuIx0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	MR Egger	61.8799481977815	47	0.0715208152363611
MAuIx0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	65.4512323777918	48	0.0476380668928033
MAuIx0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.405869463375361	48	1
mHDodB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	Maximum likelihood	81.0157428904706	47	0.00149923315745669
mHDodB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	MR Egger	80.2489464532941	46	0.00131844984425039
mHDodB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	Inverse variance weighted	81.0345130028638	47	0.00149263302410245
mHDodB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0650841757972994	47	1
mHDodB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	Maximum likelihood	73.3585882673266	47	0.00826289296680822
mHDodB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	MR Egger	73.2629458982458	46	0.00645675476411895
mHDodB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	Inverse variance weighted	73.3635743278188	47	0.00825424120306261
mHDodB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0758675838594369	47	1
mHDodB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	Maximum likelihood	54.0375987067677	45	0.167352618597863
mHDodB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	MR Egger	52.0798054470388	44	0.18842349849943
mHDodB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	Inverse variance weighted	54.0820331383999	45	0.166316713006778
mHDodB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int_imputed.txt_snps.txt	Unweighted regression	0.373725460449265	45	1
MoyByZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	54.7251011258743	54	0.446860216013482
MoyByZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	52.9096145940739	53	0.477656833330919
MoyByZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	54.7251554833418	54	0.446858168267027
MoyByZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0624527338226835	54	1
MoyByZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	50.2922987883518	54	0.618179502550013
MoyByZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	48.3541355242008	53	0.655368386925511
MoyByZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	50.2952823945111	54	0.618064811819605
MoyByZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.104721514635852	54	1
MoyByZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	71.0508320995739	54	0.0597516959447475
MoyByZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	70.8320073661736	53	0.0513478976273891
MoyByZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	71.0620416206202	54	0.0596450024271154
MoyByZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.811527903021043	54	1
msnIOT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	54.7918486238591	46	0.175537565190795
msnIOT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	54.7286418754519	45	0.151771153004759
msnIOT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	54.8019609516034	46	0.175295445240128
msnIOT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.034560476644271	46	1
msnIOT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	48.4909335997716	46	0.372809313918989
msnIOT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	48.49208463281	45	0.334001590835141
msnIOT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	48.4937208862667	46	0.372703252691606
msnIOT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0530338143390995	46	1
msnIOT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	56.1722248740052	44	0.103154111402159
msnIOT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	56.0448111790996	43	0.0876178888591444
msnIOT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	56.1816587785737	44	0.103000741650745
msnIOT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.3987553548731	44	1
n9UlAX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	Maximum likelihood	5.09676892620451	6	0.531463127367871
n9UlAX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	MR Egger	4.09065897898181	5	0.536438566104083
n9UlAX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	Inverse variance weighted	5.1043535390031	6	0.530500459455044
n9UlAX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int_imputed.txt_snps.txt	Unweighted regression	0.00197354086279634	6	0.999999999839979
n9UlAX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	Maximum likelihood	4.19191116977433	6	0.650723514204697
n9UlAX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	MR Egger	3.68076970623787	5	0.596228302329305
n9UlAX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	Inverse variance weighted	4.19191679318059	6	0.650722754855311
n9UlAX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int_imputed.txt_snps.txt	Unweighted regression	0.00178027759270828	6	0.999999999882529
n9UlAX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	Maximum likelihood	3.79684173049402	6	0.704146656781764
n9UlAX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	MR Egger	3.41279491163998	5	0.63662196819235
n9UlAX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	Inverse variance weighted	3.80423388142705	6	0.703148808480683
n9UlAX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int_imputed.txt_snps.txt	Unweighted regression	0.0100947262239371	6	0.999999978649966
nabSrp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.5410904843058	22	0.000676234871764331
nabSrp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	49.5460130404205	21	0.000421764841721332
nabSrp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	49.546225302839	22	0.00067516077299614
nabSrp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.029116908061601	22	1
nabSrp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.6620914049361	22	0.0420107999622395
nabSrp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	34.6191157581292	21	0.0310736298180135
nabSrp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.663051399	22	0.0420011860181804
nabSrp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0342061055322123	22	1
nabSrp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	28.9123894853262	21	0.116120813061646
nabSrp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	27.8824453214106	20	0.11221147252736
nabSrp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	28.9129788897307	21	0.116106448508055
nabSrp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.203932513018117	21	1
nLcyQE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	57.5186443111015	37	0.0168940067871735
nLcyQE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	MR Egger	56.962420285419	36	0.0145080868312128
nLcyQE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	57.5330224599294	37	0.016841648667921
nLcyQE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0519843320291078	37	1
nLcyQE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	56.8252404449993	37	0.0196010464461799
nLcyQE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	MR Egger	55.71615504246	36	0.0190456992840563
nLcyQE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	56.8463569462669	37	0.0195131390066
nLcyQE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0875177534875963	37	1
nLcyQE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	38.5426317267005	35	0.312396623856103
nLcyQE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	MR Egger	35.8508631117321	34	0.38166909316558
nLcyQE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	38.6211303011591	35	0.309295193281684
nLcyQE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.239345664931735	35	1
NOD6GB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	58.7083657074739	49	0.161361610046842
NOD6GB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	MR Egger	58.4374966719377	48	0.143769242479854
NOD6GB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	58.7213894543175	49	0.161076527333757
NOD6GB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0696338715499369	49	1
NOD6GB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	46.4811699147847	49	0.575829435416215
NOD6GB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	MR Egger	46.4972233531783	48	0.534553085692528
NOD6GB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	46.497232089837	49	0.575171772511118
NOD6GB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.079988321779273	49	1
NOD6GB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	51.230572659994	48	0.34814425910943
NOD6GB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	MR Egger	51.2635785328616	47	0.310142542483741
NOD6GB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	51.2980677871583	48	0.345712606323539
NOD6GB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.618738640449493	48	1
nTrWBB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	65.5227780384568	51	0.0830130604309258
nTrWBB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	65.329056807895	50	0.0715163682213454
nTrWBB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	65.5253876610104	51	0.0829796210714926
nTrWBB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0747237444443062	51	1
nTrWBB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.2894693058772	51	0.115901146708564
nTrWBB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	63.2883009197492	50	0.098192687000739
nTrWBB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.2896668695435	51	0.115897839816798
nTrWBB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.126507278952098	51	1
nTrWBB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.8195680721818	49	0.181699496959662
nTrWBB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	57.4795369585722	48	0.164203597476962
nTrWBB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.8644912247149	49	0.180629499387194
nTrWBB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.402633323398675	49	1
nxaEKK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	61.5283952214775	58	0.350923490560122
nxaEKK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	MR Egger	61.5006087975328	57	0.318105754152996
nxaEKK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	61.5301310540377	58	0.350866095383046
nxaEKK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0665118934747559	58	1
nxaEKK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	62.0796265661766	58	0.332926865408254
nxaEKK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	MR Egger	62.0611493620801	57	0.300585310658577
nxaEKK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	62.0797930108285	58	0.332921502351003
nxaEKK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.109468880407716	58	1
nxaEKK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	69.9831855337474	55	0.0840200323004236
nxaEKK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	MR Egger	69.4513756754142	54	0.0767039967822533
nxaEKK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	70.0149120880153	55	0.0836231614976395
nxaEKK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.474653182125158	55	1
o27rm2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	77.696134152225	46	0.00239916904596279
o27rm2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	MR Egger	77.4490652998495	45	0.0018771214620918
o27rm2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	77.6961620960421	46	0.0023991535893691
o27rm2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0755938351280092	46	1
o27rm2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	61.7375480488651	46	0.0603668758842767
o27rm2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	MR Egger	61.723549078125	45	0.0494088925486688
o27rm2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	61.7376612360228	46	0.060365713672674
o27rm2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.112259359832941	46	1
o27rm2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	57.5972749356938	43	0.0674945260409149
o27rm2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	MR Egger	54.6788088688632	42	0.090833658006699
o27rm2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	57.7077723196768	43	0.0662232200795503
o27rm2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.37947589798828	43	1
OAElrr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	103.285694697527	63	0.0010345188884146
OAElrr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	MR Egger	98.7579640472495	62	0.00207102802361829
OAElrr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	103.310682208816	63	0.00102893933209384
OAElrr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.110380396289429	63	1
OAElrr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	89.8510500900578	63	0.014803022179057
OAElrr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	MR Egger	88.8992433566976	62	0.0141694854374381
OAElrr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	89.8577901966902	63	0.0147852416045071
OAElrr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.130214024426099	63	1
OAElrr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	72.6920275596927	61	0.145234706708849
OAElrr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	MR Egger	68.048720317178	60	0.222285213112673
OAElrr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	72.835526266629	61	0.142615375595487
OAElrr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.472388335949823	61	1
ocrs2f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	116.918762048913	71	0.000493098572950156
ocrs2f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	MR Egger	116.951394236174	70	0.000370644619198353
ocrs2f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	116.951555235937	71	0.000489626961449724
ocrs2f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.175012365888756	71	1
ocrs2f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	110.446952501777	71	0.00189307113215815
ocrs2f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	MR Egger	110.197699083493	70	0.00154797297502152
ocrs2f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	110.508358614116	71	0.00186994772861763
ocrs2f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.250853839253032	71	1
ocrs2f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	72.8910704755503	66	0.261840422227499
ocrs2f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	MR Egger	70.7988989095013	65	0.290369589154557
ocrs2f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	72.9110093677286	66	0.261312270292818
ocrs2f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.548775269301001	66	1
OVkUfV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	62.831274610813	34	0.00188781481325409
OVkUfV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	MR Egger	61.6829076105956	33	0.00178889989420493
OVkUfV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	62.8894780239509	34	0.00185957273045907
OVkUfV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0621928209988154	34	1
OVkUfV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	60.3561958513333	34	0.00354373508983465
OVkUfV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	MR Egger	60.3829436339058	33	0.00250769398953329
OVkUfV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	60.408501398005	34	0.00349769667549492
OVkUfV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.103294929468722	34	1
OVkUfV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	28.242475967588	33	0.703046607143865
OVkUfV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	MR Egger	27.7833551086558	32	0.68003257227656
OVkUfV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	28.3530550766498	33	0.697812005109379
OVkUfV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.218545776778007	33	1
oVmeBf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.4923716824004	36	0.113070372595467
oVmeBf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	45.2655235647328	35	0.11466021967454
oVmeBf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	46.4971451855203	36	0.11297940469082
oVmeBf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.054931797771454	36	1
oVmeBf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	44.8334936097038	36	0.148357460821219
oVmeBf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	43.9400483380831	35	0.142913577195072
oVmeBf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	44.833579031419	36	0.148355448338929
oVmeBf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0755360482428154	36	1
oVmeBf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.677129963943	34	0.345705172751368
oVmeBf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	35.2387282080689	33	0.362682305404321
oVmeBf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.7016408957155	34	0.34466554373642
oVmeBf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.29932471243833	34	1
OVw1cA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	75.6944854022979	45	0.00282446267532788
OVw1cA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	75.0650680315802	44	0.00241959604847834
OVw1cA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	75.7000891496217	45	0.00282082364644106
OVw1cA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0969688785176444	45	1
OVw1cA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.8151813459201	45	0.0338086271859612
OVw1cA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	63.2991928599919	44	0.0297381365800234
OVw1cA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.8188854170229	45	0.0337853537256103
OVw1cA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.123326252890194	45	1
OVw1cA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	59.4453347316469	41	0.0311491380759955
OVw1cA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	59.2612184072172	40	0.0254084485994643
OVw1cA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.4926975453613	41	0.0308630070720032
OVw1cA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.535778334468859	41	1
P1kZg6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	Maximum likelihood	0.340191255678608	2	0.843584142610277
P1kZg6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	MR Egger	0.276009153107258	1	0.599328970210971
P1kZg6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	Inverse variance weighted	0.344924774599815	2	0.841589942686591
P1kZg6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int_imputed.txt_snps.txt	Unweighted regression	0.000802686323158334	2	0.999598737365814
P1kZg6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	Maximum likelihood	1.19690328050085	2	0.549662052146545
P1kZg6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	MR Egger	1.20577748545612	1	0.272169995335578
P1kZg6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	Inverse variance weighted	1.22335228784232	2	0.54244089765282
P1kZg6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int_imputed.txt_snps.txt	Unweighted regression	0.00501494040997843	2	0.997495670872491
P1kZg6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	Maximum likelihood	1.2378265038816	2	0.538529365445223
P1kZg6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	MR Egger	0.672194642989115	1	0.412287499476487
P1kZg6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	Inverse variance weighted	1.25049661837948	2	0.535128534687438
P1kZg6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int_imputed.txt_snps.txt	Unweighted regression	0.0165907154735179	2	0.991738953802186
P3OGcd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	73.4068701806012	40	0.000998756122176181
P3OGcd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	MR Egger	73.4282380974521	39	0.000702006861848099
P3OGcd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	73.4481117350047	40	0.000988371751471715
P3OGcd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0868449070383416	40	1
P3OGcd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	74.7441386678583	40	0.000709784637586837
P3OGcd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	MR Egger	74.6287692486688	39	0.000512874892774462
P3OGcd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	74.7456313523154	40	0.000709511943320196
P3OGcd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.154973832442506	40	1
P3OGcd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	Maximum likelihood	37.4077232060841	39	0.542593188951393
P3OGcd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	MR Egger	36.1534510039243	38	0.555064075537177
P3OGcd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	37.5478605489394	39	0.536133328234373
P3OGcd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.210253670851283	39	1
PDLt3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	49.6148193839497	47	0.369427013778825
PDLt3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	MR Egger	49.065431896704	46	0.351246416571799
PDLt3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	49.6389031513353	47	0.36852431835638
PDLt3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0466801296851603	47	1
PDLt3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	51.3869763702094	47	0.30592418936014
PDLt3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	MR Egger	49.7108791064599	46	0.327773950576647
PDLt3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	51.4007613641482	47	0.305454945109183
PDLt3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0763084311865308	47	1
PDLt3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	46.7529615893557	46	0.441345183308311
PDLt3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	MR Egger	46.3971998191199	45	0.414514228674853
PDLt3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	46.7873065671225	46	0.439949745437264
PDLt3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.640362884249775	46	1
pf5i0s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	Maximum likelihood	15.6646560045534	8	0.0474392801527244
pf5i0s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	MR Egger	13.4221027322193	7	0.062467833269268
pf5i0s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	Inverse variance weighted	15.7051983761341	8	0.046799325433205
pf5i0s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int_imputed.txt_snps.txt	Unweighted regression	0.0176706693892004	8	0.999999999747877
pf5i0s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	Maximum likelihood	11.5823477736777	8	0.170833688409741
pf5i0s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	MR Egger	9.70208856425545	7	0.20609372725082
pf5i0s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	Inverse variance weighted	11.628935509614	8	0.168543473724859
pf5i0s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int_imputed.txt_snps.txt	Unweighted regression	0.018218045303182	8	0.999999999715219
pf5i0s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	Maximum likelihood	13.2292648049828	8	0.104201016627657
pf5i0s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	MR Egger	12.4530646365616	7	0.0866099149344008
pf5i0s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	Inverse variance weighted	13.2405527133867	8	0.103836614159373
pf5i0s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int_imputed.txt_snps.txt	Unweighted regression	0.107977327104695	8	0.999999660954165
PghYqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	43.4026528090109	25	0.0126379918665138
PghYqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	41.9569984233135	24	0.0130485644341538
PghYqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	43.4303057854694	25	0.0125492960542092
PghYqS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.037012566639736	25	1
PghYqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	37.091347941191	25	0.0565947225018114
PghYqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	36.9175838319129	24	0.044595380274419
PghYqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	37.1168241839717	25	0.056279703253703
PghYqS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0488312327534495	25	1
PghYqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	25.9687931183661	25	0.409265580598432
PghYqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	25.7282574179862	24	0.367095849922515
PghYqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	25.9688001907762	25	0.409265202493629
PghYqS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.23350291252576	25	1
PhLzfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	Maximum likelihood	0.887623768110654	3	0.828413405154782
PhLzfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	MR Egger	0.874499216971855	2	0.645810211581433
PhLzfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	Inverse variance weighted	0.887772856717594	3	0.828377452912637
PhLzfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int_imputed.txt_snps.txt	Unweighted regression	0.000349756516398577	3	0.999998260509905
PhLzfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	Maximum likelihood	1.17861972916073	3	0.758136617765863
PhLzfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	MR Egger	1.12919144018977	2	0.568589969797029
PhLzfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	Inverse variance weighted	1.17866446157566	3	0.758125870833753
PhLzfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int_imputed.txt_snps.txt	Unweighted regression	0.000485722279531084	3	0.999997153327142
PhLzfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	Maximum likelihood	4.92758402796217	3	0.177177248407063
PhLzfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	MR Egger	1.49379583659075	2	0.473834147504705
PhLzfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	Inverse variance weighted	4.92975152726805	3	0.177013948022421
PhLzfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int_imputed.txt_snps.txt	Unweighted regression	0.0267819929144074	3	0.998843631021252
pjoouy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	81.3435333650258	56	0.0151024221373017
pjoouy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	MR Egger	75.621323081325	55	0.0339940694011396
pjoouy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	81.3536766184623	56	0.0150738999722719
pjoouy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.0771488396917929	56	1
pjoouy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	89.2441146713066	56	0.00313093971653312
pjoouy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	MR Egger	82.8535585994368	55	0.00895870848712382
pjoouy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	89.255654865183	56	0.00312331135586426
pjoouy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.121365681748019	56	1
pjoouy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	Maximum likelihood	71.3926043516234	53	0.0467964791000608
pjoouy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	MR Egger	66.1868545723912	52	0.0892073736021313
pjoouy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	Inverse variance weighted	71.3947174202028	53	0.0467799990386523
pjoouy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int_imputed.txt_snps.txt	Unweighted regression	0.503819549881301	53	1
pWE5uQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	70.8929732564511	56	0.0868148079820818
pWE5uQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	70.2830030169078	55	0.0803301818335675
pWE5uQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	70.9194969529423	56	0.0864765892287523
pWE5uQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0774604732040075	56	1
pWE5uQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.8407949305756	56	0.0470704906473533
pWE5uQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	71.2114673263552	55	0.0697365039210611
pWE5uQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.8407949305756	56	0.0470704906473533
pWE5uQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.122091535586655	56	1
pWE5uQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.2778012053455	54	0.389678170839881
pWE5uQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	56.3871088414149	53	0.349489003203595
pWE5uQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.4253055405302	54	0.384401717559914
pWE5uQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.643581003902855	54	1
Q2xVYE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	74.8150265107379	48	0.00790851057443643
Q2xVYE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	74.6125511112148	47	0.00633168482342463
Q2xVYE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	74.817075814518	48	0.00790512078345793
Q2xVYE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.092454026536091	48	1
Q2xVYE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	61.9064185176487	48	0.0856267428726944
Q2xVYE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	61.3379007742979	47	0.0781186389018877
Q2xVYE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	61.9064400849323	48	0.085626452006552
Q2xVYE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.113662055008275	48	1
Q2xVYE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	51.5592083310964	44	0.20214493106101
Q2xVYE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	MR Egger	50.8792782406984	43	0.191166143672939
Q2xVYE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	51.6071587835165	44	0.200852778133485
Q2xVYE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.483881695769933	44	1
Q5Ct93	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	67.1552475156951	50	0.0530309596234252
Q5Ct93	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	66.6034359905268	49	0.0477858643782032
Q5Ct93	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	67.1591883961634	50	0.0529959362608987
Q5Ct93	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0996517846061176	50	1
Q5Ct93	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.5847841172725	50	0.0583126461307959
Q5Ct93	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	65.0780237497242	49	0.0617797439145033
Q5Ct93	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.5925947145216	50	0.058237433682224
Q5Ct93	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.132820045295903	50	1
Q5Ct93	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	46.8608810714669	48	0.519520536642645
Q5Ct93	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	46.384195816939	47	0.497961189644039
Q5Ct93	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	47.0501948326261	48	0.511713386740382
Q5Ct93	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.380555374235968	48	1
Q6I4w5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	79.2344097603613	46	0.00167660774049215
Q6I4w5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	76.4878768133129	45	0.0023508549690369
Q6I4w5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	79.3614564709583	46	0.00162718189831707
Q6I4w5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.046314675658239	46	1
Q6I4w5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	68.3677799819085	46	0.0177866025336525
Q6I4w5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	66.5723694574066	45	0.0199326574062688
Q6I4w5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	68.5182715496138	46	0.0172640920281157
Q6I4w5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0622971341570722	46	1
Q6I4w5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	52.4333016410088	46	0.238672359722674
Q6I4w5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	47.9530594878297	45	0.353944914716351
Q6I4w5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	52.5677083501081	46	0.234716683302072
Q6I4w5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.283316561428551	46	1
Qe3LZN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	45.7892750892347	36	0.127117522409414
Qe3LZN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	MR Egger	45.505784519485	35	0.110049109481619
Qe3LZN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	45.8441721186581	36	0.125973658787162
Qe3LZN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0284122788821008	36	1
Qe3LZN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.7241120729401	36	0.091470362704568
Qe3LZN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	MR Egger	47.6995149144017	35	0.0744995595045648
Qe3LZN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.8367848335272	36	0.0896753200267274
Qe3LZN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0570696726024743	36	1
Qe3LZN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	34.9518299682014	36	0.518299769351812
Qe3LZN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	MR Egger	34.7943320892783	35	0.477990746740722
Qe3LZN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	34.9905492672471	36	0.516448377956068
Qe3LZN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.334030308955315	36	1
qffR22	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	Maximum likelihood	23.2565702065332	16	0.107046028142069
qffR22	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	MR Egger	23.2590409194913	15	0.0787926747013843
qffR22	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	23.260017151694	16	0.106958462340745
qffR22	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0238121870412473	16	1
qffR22	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	Maximum likelihood	19.4356529493545	16	0.246719968851486
qffR22	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	MR Egger	17.8224342561955	15	0.272115789575115
qffR22	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	19.4356534154696	16	0.246719946068102
qffR22	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.0257592589045327	16	1
qffR22	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	Maximum likelihood	30.7128265026424	16	0.0146382214291734
qffR22	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	MR Egger	27.7570568262608	15	0.0231402015334347
qffR22	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	Inverse variance weighted	30.7150583442886	16	0.0146286738342227
qffR22	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int_imputed.txt_snps.txt	Unweighted regression	0.313489863645593	16	0.999999999992137
QnTM9x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	25.1569672630215	27	0.565665609317426
QnTM9x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	25.1338606680137	26	0.511408299235732
QnTM9x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	25.1635806521395	27	0.565295062268763
QnTM9x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0644149664099011	27	1
QnTM9x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	17.8827502068446	27	0.907062538787958
QnTM9x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	17.8846356263313	26	0.879930241545867
QnTM9x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	17.890659277713	27	0.906826127935832
QnTM9x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.049385111995427	27	1
QnTM9x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	26.4712659313589	26	0.437449298548537
QnTM9x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	26.2166509923385	25	0.396110318213376
QnTM9x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	26.4716577543886	26	0.437428188304713
QnTM9x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.272194569455958	26	1
QsOOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	64.5081026488202	56	0.203614409245171
QsOOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	MR Egger	63.4247546132711	55	0.203717421780709
QsOOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	64.5516046436846	56	0.202558211601382
QsOOWT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0662687911328328	56	1
QsOOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	68.2870360839762	56	0.125583613921464
QsOOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	MR Egger	68.1640718965534	55	0.109450187791149
QsOOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	68.3145468767884	56	0.125113885363111
QsOOWT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.099195205000311	56	1
QsOOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	62.7556265940046	54	0.193729953462005
QsOOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	MR Egger	62.8215225540533	53	0.167387265282906
QsOOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	62.8513717762573	54	0.191451388215054
QsOOWT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.537712154602833	54	1
QUTCc7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.5672470344347	59	0.288363071714674
QUTCc7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	58.5443845812431	58	0.45529734513306
QUTCc7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.6652801289286	59	0.285472269189726
QUTCc7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0711413227620693	59	1
QUTCc7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	63.2980240115552	59	0.327255622872475
QUTCc7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	59.3143306822004	58	0.427416230081115
QUTCc7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	63.4099531096958	59	0.323719696354547
QUTCc7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0999906975537389	59	1
QUTCc7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.3931036592932	56	0.612190884388122
QUTCc7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	51.6417027661884	55	0.6037299027872
QUTCc7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.5360462990172	56	0.606781047536699
QUTCc7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.534547711220976	56	1
QvrjbM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	96.3665998881773	58	0.00116121258911256
QvrjbM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	MR Egger	94.5133081055228	57	0.00131774985917488
QvrjbM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	96.3689443932691	58	0.00116060984138552
QvrjbM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0990852766296464	58	1
QvrjbM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	78.8658767539084	58	0.0355800774626898
QvrjbM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	MR Egger	78.273160560657	57	0.0322780496580839
QvrjbM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	78.8659825050943	58	0.0355794498965846
QvrjbM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0991470020632935	58	1
QvrjbM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	65.893906714353	55	0.149234548951928
QvrjbM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	MR Egger	59.9373918493492	54	0.269186740310416
QvrjbM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	65.9650142902502	55	0.147842970165633
QvrjbM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.323246288554724	55	1
QwF3Mu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	77.148328101604	53	0.0168254498803392
QwF3Mu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	MR Egger	71.58859936487	52	0.037098517705108
QwF3Mu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	77.1734364596388	53	0.0167460472852297
QwF3Mu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0615901466039508	53	1
QwF3Mu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	73.9106929442446	53	0.030376468722758
QwF3Mu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	MR Egger	69.730423156252	52	0.0508525445592014
QwF3Mu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	73.9361038298799	53	0.0302405254645308
QwF3Mu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0934536267576738	53	1
QwF3Mu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	60.7399092006627	53	0.217088906734811
QwF3Mu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	MR Egger	56.1627121741103	52	0.321759251859338
QwF3Mu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	60.7845572246774	53	0.215928068877612
QwF3Mu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.433426430781657	53	1
rcLsCy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	57.6133595652767	35	0.00939267729382612
rcLsCy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	MR Egger	54.0517209344339	34	0.0158248942404369
rcLsCy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	57.6144568327768	35	0.00939029148158196
rcLsCy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.037618902681893	35	1
rcLsCy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	66.0051844936742	35	0.00117556841258146
rcLsCy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	MR Egger	64.2955843500843	34	0.00128742681614905
rcLsCy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	66.0081962392479	35	0.00117463907651241
rcLsCy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0523044605580799	35	1
rcLsCy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.6670687255128	34	0.060003906243076
rcLsCy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	MR Egger	46.9464016001325	33	0.0547123049959457
rcLsCy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.6694729632701	34	0.0599761420680884
rcLsCy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.24966109784596	34	1
rkAPX3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	64.7672284841697	54	0.149759833850988
rkAPX3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	63.8448220541385	53	0.146218500921847
rkAPX3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	64.8292311565137	54	0.148532771560707
rkAPX3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0512535653101004	54	1
rkAPX3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	63.1369574335553	54	0.184766281332498
rkAPX3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	62.8964145395875	53	0.165766166511271
rkAPX3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	63.2227864683051	54	0.182789685425789
rkAPX3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0806539563562842	54	1
rkAPX3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	64.7314462309719	54	0.150471403521568
rkAPX3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	59.0544308028002	53	0.263933258939107
rkAPX3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	64.7476058158666	54	0.150149741895351
rkAPX3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.443537248635375	54	1
rLYplx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	66.9127305850969	51	0.0667014360468658
rLYplx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	MR Egger	66.8906299785583	50	0.0554281292877342
rLYplx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	66.9142814878008	51	0.0666848470602642
rLYplx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0635716080072298	51	1
rLYplx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	64.6495809646273	51	0.0948343451764035
rLYplx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	MR Egger	64.6433090314983	50	0.0797187536180361
rLYplx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	64.6537961849474	51	0.0947741831965673
rLYplx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.106323691217688	51	1
rLYplx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	69.5013333480846	50	0.0353832181830529
rLYplx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	MR Egger	68.0830452477907	49	0.0369020292005835
rLYplx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	69.5126600592686	50	0.0353122472824554
rLYplx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.70185294232538	50	1
RYe5D8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	Maximum likelihood	78.0942830518759	42	0.000602156331315496
RYe5D8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	MR Egger	78.0704507434734	41	0.000426488006303809
RYe5D8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	Inverse variance weighted	78.0944709527942	42	0.000602127451715717
RYe5D8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0865354734193673	42	1
RYe5D8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	Maximum likelihood	68.3562935468664	42	0.00623558033939823
RYe5D8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	MR Egger	68.2947932316135	41	0.00472975276650885
RYe5D8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	Inverse variance weighted	68.3734238855574	42	0.00621173356771034
RYe5D8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int_imputed.txt_snps.txt	Unweighted regression	0.114435789785823	42	1
RYe5D8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	Maximum likelihood	37.5935616688654	40	0.579118614059082
RYe5D8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	MR Egger	31.393880051095	39	0.801703065082978
RYe5D8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	Inverse variance weighted	37.6083737480108	40	0.578444464177133
RYe5D8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int_imputed.txt_snps.txt	Unweighted regression	0.231103489712927	40	1
sDH85h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	Maximum likelihood	54.2031663685822	38	0.04275566894504
sDH85h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	MR Egger	50.8047458697745	37	0.0648532288507186
sDH85h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	Inverse variance weighted	54.2215683265328	38	0.0426040833471113
sDH85h	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int_imputed.txt_snps.txt	Unweighted regression	0.0417213243867385	38	1
sDH85h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	Maximum likelihood	51.12841011058	38	0.0755906617670539
sDH85h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	MR Egger	49.3389835947159	37	0.0844349719131006
sDH85h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	Inverse variance weighted	51.2157691839604	38	0.0744262198708476
sDH85h	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int_imputed.txt_snps.txt	Unweighted regression	0.0621961523634125	38	1
sDH85h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	Maximum likelihood	39.0549342032532	36	0.334161315178076
sDH85h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	MR Egger	37.8653056433617	35	0.339873660092177
sDH85h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	Inverse variance weighted	39.1108253765135	36	0.331897888914366
sDH85h	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int_imputed.txt_snps.txt	Unweighted regression	0.164323058439148	36	1
sJxzjb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	39.9225752366152	32	0.158522272612603
sJxzjb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	MR Egger	36.0518640612548	31	0.24402280890381
sJxzjb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	39.9274825337706	32	0.158394354649374
sJxzjb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0387400486793993	32	1
sJxzjb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	41.7295595480602	32	0.116519763629101
sJxzjb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	MR Egger	40.2488110573843	31	0.123524637450948
sJxzjb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	41.7371377127598	32	0.116364327669404
sJxzjb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.0542129868720497	32	1
sJxzjb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	Maximum likelihood	27.8641591417441	31	0.628168989533165
sJxzjb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	MR Egger	26.5149377512075	30	0.648609461907959
sJxzjb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	Inverse variance weighted	27.8650548292729	31	0.62812286830057
sJxzjb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int_imputed.txt_snps.txt	Unweighted regression	0.203192923568049	31	1
So8fhc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	Maximum likelihood	97.3534226346256	47	2.25098253223064e-05
So8fhc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	MR Egger	95.787340770929	46	2.34440203112729e-05
So8fhc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	Inverse variance weighted	97.359301928274	47	2.24732336677955e-05
So8fhc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int_imputed.txt_snps.txt	Unweighted regression	0.0819304064786462	47	1
So8fhc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	Maximum likelihood	89.1272927055103	47	0.000202948420190828
So8fhc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	MR Egger	86.5904105958995	46	0.000274470952134241
So8fhc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	Inverse variance weighted	89.1297765116743	47	0.000202818700988906
So8fhc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int_imputed.txt_snps.txt	Unweighted regression	0.0969715553304926	47	1
So8fhc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	Maximum likelihood	65.4547978485319	46	0.031121688078996
So8fhc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	MR Egger	62.1329356558889	45	0.0459416367259934
So8fhc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	Inverse variance weighted	65.470100672754	46	0.0310331450341301
So8fhc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int_imputed.txt_snps.txt	Unweighted regression	0.456547754875882	46	1
sRlXUf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	112.447270665839	79	0.00800209892163115
sRlXUf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	MR Egger	111.819788295079	78	0.00725143053278605
sRlXUf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	112.468962382416	79	0.00797216768056475
sRlXUf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.142334206141827	79	1
sRlXUf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	110.655442922171	79	0.0108588703855784
sRlXUf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	MR Egger	110.699078294948	78	0.00880891845335543
sRlXUf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	110.705056629135	79	0.0107687037100276
sRlXUf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.204543315691789	79	1
sRlXUf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	76.9632467747113	74	0.383976015135453
sRlXUf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	MR Egger	72.6304643104403	73	0.490187754080423
sRlXUf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	76.9640590245069	74	0.38395119043918
sRlXUf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.585325916718656	74	1
sSwphp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	Maximum likelihood	76.583883487854	46	0.00309436723101142
sSwphp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	MR Egger	76.5149741439051	45	0.00233608139117819
sSwphp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	Inverse variance weighted	76.6046158974585	46	0.00307983677398661
sSwphp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int_imputed.txt_snps.txt	Unweighted regression	0.0658342791086243	46	1
sSwphp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	Maximum likelihood	69.7092541633233	46	0.0135935148622293
sSwphp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	MR Egger	69.615360882822	45	0.0107418786163108
sSwphp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	Inverse variance weighted	69.7385045005572	46	0.0135130287863989
sSwphp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int_imputed.txt_snps.txt	Unweighted regression	0.0799574293675877	46	1
sSwphp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	Maximum likelihood	37.9198806779558	45	0.763676372454831
sSwphp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	MR Egger	36.0501633997582	44	0.7974043538944
sSwphp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	Inverse variance weighted	37.9215207170894	45	0.763616661021334
sSwphp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int_imputed.txt_snps.txt	Unweighted regression	0.162196860441379	45	1
sT2Xbm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	120.132007619442	70	0.000182388167597593
sT2Xbm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	MR Egger	119.770585967807	69	0.000147131813534756
sT2Xbm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	120.149419192656	70	0.000181670594108293
sT2Xbm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.184201744629822	70	1
sT2Xbm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	105.987755695765	70	0.00356692304750371
sT2Xbm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	MR Egger	105.862905429268	69	0.00287520314499338
sT2Xbm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	106.019894209914	70	0.00354487825576979
sT2Xbm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.263412026566188	70	1
sT2Xbm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	75.9098916765182	66	0.189381662355023
sT2Xbm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	MR Egger	72.005115170295	65	0.257324435014614
sT2Xbm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	75.9543285114499	66	0.188429418168544
sT2Xbm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.546397258540751	66	1
T4MR7S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	79.6358427920556	60	0.045814242684311
T4MR7S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	79.0467896841678	59	0.0418222439042314
T4MR7S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	79.6449051180921	60	0.0457483284869094
T4MR7S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0961968840616195	60	1
T4MR7S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	66.9946499553963	60	0.249644842898938
T4MR7S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	66.0199983104397	59	0.247274231462957
T4MR7S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	67.0144398934998	60	0.249112517404058
T4MR7S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.116300371126663	60	1
T4MR7S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	Maximum likelihood	71.5614564007083	60	0.145864377420776
T4MR7S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	MR Egger	71.5457781066078	59	0.126657659035961
T4MR7S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	71.5699390161154	60	0.145706892249477
T4MR7S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int_imputed.txt_snps.txt	Unweighted regression	1.27786859362177	60	1
T7A7rm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	76.1541913873159	39	0.000342092649328356
T7A7rm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	75.5006452140157	38	0.000280546372239742
T7A7rm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	76.2248397324866	39	0.000335682322879547
T7A7rm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0481819071920059	39	1
T7A7rm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	58.5545203218099	39	0.022875169746646
T7A7rm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	58.5573397629498	38	0.017658586056812
T7A7rm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	58.591367904102	39	0.0227026232590995
T7A7rm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0625688021025109	39	1
T7A7rm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.9117338752414	39	0.113134054456754
T7A7rm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	44.9884501238168	38	0.202526470633667
T7A7rm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.0298619944397	39	0.110973127103543
T7A7rm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.330827247994127	39	1
T8Thpt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	65.2373393287692	40	0.00708826872453239
T8Thpt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	62.4478582497498	39	0.00995635762730862
T8Thpt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	65.3047205152449	40	0.00698133563310689
T8Thpt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0443729189465638	40	1
T8Thpt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.8021909095801	40	0.018540408598768
T8Thpt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	58.8799147802658	39	0.0213912893852397
T8Thpt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	60.8109538870063	40	0.01850667693859
T8Thpt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0683806860758911	40	1
T8Thpt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	47.0397705542406	40	0.206474179160025
T8Thpt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	44.6881857151624	39	0.245137636398645
T8Thpt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	47.0510884153257	40	0.206150499112611
T8Thpt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.457130299050233	40	1
TBg1Zp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	22.0623735594371	18	0.229227719537648
TBg1Zp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	20.9162659769899	17	0.230058170318375
TBg1Zp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	22.0775831796568	18	0.22855890108725
TBg1Zp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0379421663211885	18	1
TBg1Zp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	17.6001826326507	18	0.482268595981662
TBg1Zp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	16.6471353700948	17	0.478509625672149
TBg1Zp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	17.6025782598504	18	0.482107564277627
TBg1Zp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0390130801691368	18	1
TBg1Zp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	15.8977582693922	17	0.531094228356839
TBg1Zp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	15.4044286399081	16	0.495240685334566
TBg1Zp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	15.925270671877	17	0.529138655495472
TBg1Zp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.220385367422444	17	0.999999999999945
TBJ7aP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	Maximum likelihood	20.5823092119295	18	0.30100713716362
TBJ7aP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	MR Egger	20.5769616031471	17	0.24578634398832
TBJ7aP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	Inverse variance weighted	20.5866391107054	18	0.300777974582931
TBJ7aP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int_imputed.txt_snps.txt	Unweighted regression	0.0154826493194952	18	1
TBJ7aP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	Maximum likelihood	16.4532616303408	18	0.560946078910309
TBJ7aP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	MR Egger	16.4542074564506	17	0.491894477136583
TBJ7aP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	Inverse variance weighted	16.4542144762738	18	0.560879786316795
TBJ7aP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int_imputed.txt_snps.txt	Unweighted regression	0.0155361912246211	18	1
TBJ7aP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	Maximum likelihood	19.4335217963448	18	0.365596672119074
TBJ7aP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	MR Egger	19.4231680805048	17	0.304790110755412
TBJ7aP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	Inverse variance weighted	19.4355744702262	18	0.365474782549314
TBJ7aP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int_imputed.txt_snps.txt	Unweighted regression	0.145386926818808	18	1
tcnZyL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	64.1753468499654	52	0.119813114210826
tcnZyL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	MR Egger	62.6052076847351	51	0.127802854122266
tcnZyL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	64.1832097426187	52	0.119679246971772
tcnZyL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0627020622454587	52	1
tcnZyL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	62.7258375223109	52	0.146528235136475
tcnZyL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	MR Egger	60.948176696447	51	0.16048713320633
tcnZyL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	62.7330773892141	52	0.146384499422364
tcnZyL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.079957762830887	52	1
tcnZyL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	67.5317564152197	50	0.0497725919539534
tcnZyL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	MR Egger	65.4865620210339	49	0.0577290982224722
tcnZyL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	67.5561059244829	50	0.0495678869158014
tcnZyL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.525569075251002	50	1
TgY0yO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	63.3604960392985	38	0.00605788298176752
TgY0yO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	MR Egger	63.1710369104245	37	0.00466900277233859
TgY0yO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	63.3747538025856	38	0.0060378544352295
TgY0yO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0534411143847576	38	1
TgY0yO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	61.5533418845354	38	0.00915930035853962
TgY0yO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	MR Egger	61.3578933645536	37	0.0071516413374074
TgY0yO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	61.5890156236179	38	0.00908598053454563
TgY0yO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.087355314019127	38	1
TgY0yO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	Maximum likelihood	35.8237549856518	36	0.476915359135981
TgY0yO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	MR Egger	30.934465934301	35	0.664779562471492
TgY0yO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	35.8976733820002	36	0.473443120208383
TgY0yO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.206042036571311	36	1
thC79f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	63.5731494570897	59	0.318599996327893
thC79f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	MR Egger	63.2922223834691	58	0.29505847391189
thC79f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	63.5735626388432	59	0.318587088567617
thC79f	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.061316160168201	59	1
thC79f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	62.8779461395586	59	0.340700578528721
thC79f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	MR Egger	62.8287131410643	58	0.309243403497635
thC79f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	62.8787850162195	59	0.34067345993599
thC79f	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0924148657675025	59	1
thC79f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	Maximum likelihood	76.9279239903142	58	0.0488182378466069
thC79f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	MR Egger	76.9557061115263	57	0.040256873922315
thC79f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	76.9782591974188	58	0.048427360682377
thC79f	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.690562892531624	58	1
tJxlRV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.0429549986243	46	0.00278719802045274
tJxlRV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	76.1583607186316	45	0.0025376872423516
tJxlRV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.1077772946299	46	0.0027462048833258
tJxlRV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0772208662897798	46	1
tJxlRV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	70.9576973631171	46	0.0105201075456208
tJxlRV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	70.1762855220986	45	0.00954832052134925
tJxlRV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	70.9579228344182	46	0.0105196151132712
tJxlRV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.116272211545334	46	1
tJxlRV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	41.5477508460976	44	0.577285580250691
tJxlRV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	41.4940070361309	43	0.536711653965006
tJxlRV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	41.787328786646	44	0.566905655684135
tJxlRV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.411206898926938	44	1
tNnJZx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	86.020220985219	55	0.00472774104255194
tNnJZx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	83.5999602455063	54	0.00602072659057132
tNnJZx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	86.0307846181869	55	0.00471742248894451
tNnJZx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0685890100280012	55	1
tNnJZx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	90.1210865773956	55	0.00197401824729636
tNnJZx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	87.6773858743882	54	0.0025483677472399
tNnJZx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	90.123003871367	55	0.00197318965194597
tNnJZx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.105166857070738	55	1
tNnJZx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	60.9304757703106	54	0.240758017099784
tNnJZx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	59.5371819751222	53	0.249919175577878
tNnJZx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	61.0782427203529	54	0.236697305812405
tNnJZx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.4860551781051	54	1
TpNrsP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	Maximum likelihood	9.6155732747155	9	0.382493063517276
TpNrsP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	MR Egger	9.58527322050522	8	0.295348416438065
TpNrsP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	Inverse variance weighted	9.6159596463423	9	0.382460016481455
TpNrsP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int_imputed.txt_snps.txt	Unweighted regression	0.0132087685985613	9	0.999999999997062
TpNrsP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	Maximum likelihood	13.7428433315928	9	0.131771330637271
TpNrsP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	MR Egger	13.7472847535123	8	0.0885948322405529
TpNrsP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	Inverse variance weighted	13.7588799179197	9	0.131164558100076
TpNrsP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int_imputed.txt_snps.txt	Unweighted regression	0.02292253244367	9	0.999999999965036
TpNrsP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	Maximum likelihood	3.5051606109665	9	0.940870754292179
TpNrsP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	MR Egger	2.9707022684378	8	0.936182646991303
TpNrsP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	Inverse variance weighted	3.50620408305189	9	0.940815335594187
TpNrsP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int_imputed.txt_snps.txt	Unweighted regression	0.0296313204853755	9	0.999999999889306
TUjS1X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.8890695767787	44	0.00399517908172514
TUjS1X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	72.9785857609341	43	0.00290839950824711
TUjS1X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.9845133156438	44	0.00390955279573223
TUjS1X	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0906575238877901	44	1
TUjS1X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.1974090653757	44	0.0046700329488535
TUjS1X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	71.9170666416159	43	0.0037187782783984
TUjS1X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.2415929983394	44	0.00462392872433179
TUjS1X	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.148419904495313	44	1
TUjS1X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	40.7948274150047	41	0.479646578872922
TUjS1X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	37.0147577889406	40	0.605399940377712
TUjS1X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	41.0104642702809	41	0.470163293734473
TUjS1X	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.301812274524437	41	1
tVmRRh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	56.6605288195288	45	0.113998272956351
tVmRRh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	MR Egger	56.2456739648534	44	0.101964842489889
tVmRRh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	56.6614077485713	45	0.113982943599826
tVmRRh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0469220561620283	45	1
tVmRRh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	53.3687194961033	45	0.183518840692571
tVmRRh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	MR Egger	53.1679232455197	44	0.161911751650374
tVmRRh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	53.3763769276818	45	0.18332765542335
tVmRRh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0672411228124807	45	1
tVmRRh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	54.7497628469484	44	0.128439199968231
tVmRRh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	MR Egger	50.4622280505446	43	0.202332440054665
tVmRRh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	54.7523082513009	44	0.128390001027683
tVmRRh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.404114738474046	44	1
tXxFDx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	60.9913417187805	41	0.0229309839651501
tXxFDx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	MR Egger	60.3864172881826	40	0.0202060182251738
tXxFDx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	61.0159951153137	41	0.0228173444519089
tXxFDx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0689200503098231	41	1
tXxFDx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	60.0350381228851	41	0.0277485041632167
tXxFDx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	MR Egger	60.0098937524173	40	0.0218292796673653
tXxFDx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	60.0444674330944	41	0.0276969146669399
tXxFDx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.133072509022723	41	1
tXxFDx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	47.6344915664425	38	0.135972547418881
tXxFDx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	MR Egger	41.3563076024408	37	0.286150731403105
tXxFDx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	47.6930651595336	38	0.134716153586161
tXxFDx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.325619368165968	38	1
U4HMJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	Maximum likelihood	70.1980278833821	40	0.00221541657716456
U4HMJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	MR Egger	69.9748499710675	39	0.00168954010208369
U4HMJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	70.2002952897748	40	0.00221419593839303
U4HMJU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0769233154820743	40	1
U4HMJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	Maximum likelihood	60.4062696509257	40	0.0201235245207264
U4HMJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	MR Egger	60.3745315499486	39	0.01562807076629
U4HMJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	60.4065733428697	40	0.020122264928306
U4HMJU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.135951740649851	40	1
U4HMJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	Maximum likelihood	47.221860990232	37	0.121075093048534
U4HMJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	MR Egger	42.2352504152312	36	0.219514116430106
U4HMJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	47.2968274514013	37	0.119591133137426
U4HMJU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.312672069248275	37	1
U5ekUz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	Maximum likelihood	82.5208459111914	45	0.000546597997105487
U5ekUz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	MR Egger	80.682509725485	44	0.000618827908195588
U5ekUz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	Inverse variance weighted	82.529306700109	45	0.000545440144945728
U5ekUz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int_imputed.txt_snps.txt	Unweighted regression	0.0772807797937663	45	1
U5ekUz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	Maximum likelihood	77.7570354951124	45	0.00174546843704993
U5ekUz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	MR Egger	76.6428772542246	44	0.00166590991853408
U5ekUz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	Inverse variance weighted	77.7598052075895	45	0.0017443249922566
U5ekUz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int_imputed.txt_snps.txt	Unweighted regression	0.129957401561142	45	1
U5ekUz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	Maximum likelihood	67.5416376855643	43	0.00982549727183238
U5ekUz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	MR Egger	67.266884964503	42	0.00793861839103765
U5ekUz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	Inverse variance weighted	67.5658260122595	43	0.0097747378161597
U5ekUz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int_imputed.txt_snps.txt	Unweighted regression	0.487489039046894	43	1
U9lOA1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	80.5175501982905	64	0.0795322196152419
U9lOA1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	78.1356149178099	63	0.0948058143073164
U9lOA1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	80.5178789086792	64	0.0795285275713759
U9lOA1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.144462471041485	64	1
U9lOA1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.762988242384	64	0.211826071034725
U9lOA1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	72.6289727008926	63	0.190418574815221
U9lOA1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.7631017661156	64	0.211823403885072
U9lOA1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.221551831546295	64	1
U9lOA1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	80.2469003324583	59	0.0343407263537832
U9lOA1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	69.8280071982139	58	0.13735032905224
U9lOA1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	80.2574261667894	59	0.0342806248660887
U9lOA1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.79027739683418	59	1
UgXT5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	42.9601894364427	32	0.093375650101292
UgXT5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	42.6001909492747	31	0.0801800865195537
UgXT5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	42.982232410055	32	0.0929981867783484
UgXT5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0520042225708245	32	1
UgXT5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	43.7856499025863	32	0.0800747394111864
UgXT5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	43.4052822273427	31	0.0686181323001537
UgXT5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	43.8260546538346	32	0.0794664427215084
UgXT5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0736195052914864	32	1
UgXT5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	34.2943864437351	31	0.312599357159232
UgXT5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	34.2936978257426	30	0.269243690686933
UgXT5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	34.3079697231892	31	0.312029482959858
UgXT5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.291695569757038	31	1
UJmJYk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	48.0368758973203	46	0.390265399393894
UJmJYk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	44.9249332647224	45	0.475106609345954
UJmJYk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	48.0439593396475	46	0.389990424683929
UJmJYk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0445461240409899	46	1
UJmJYk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	43.1638677064218	46	0.591752011191637
UJmJYk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	38.0110367059142	45	0.760347612919748
UJmJYk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	43.1646895811916	46	0.591717330810317
UJmJYk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0704231937954229	46	1
UJmJYk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	62.3040970113122	46	0.0547815914625401
UJmJYk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	MR Egger	61.4606952752544	45	0.0517515273642319
UJmJYk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	62.3141012871461	46	0.0546870521109676
UJmJYk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.730331505143835	46	1
unCChz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	66.7043390888063	31	0.000203524060309861
unCChz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	MR Egger	64.5342288802493	30	0.000251529263511673
unCChz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	66.7319389106964	31	0.000201887304229085
unCChz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0386556283277175	31	1
unCChz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	66.5116238161813	31	0.000215315276150161
unCChz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	MR Egger	65.7645745504879	30	0.000174963316566981
unCChz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	66.5375951513077	31	0.000213688592207571
unCChz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0504418872888965	31	1
unCChz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	40.9245670983967	30	0.088163116782319
unCChz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	MR Egger	40.1345822606242	29	0.0817604201804478
unCChz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	40.9293550153121	30	0.0880827188968265
unCChz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.21078966426126	30	1
UTCc3E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	Maximum likelihood	6.94470256797538	12	0.861246090672051
UTCc3E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	MR Egger	6.538736879869	11	0.835114022446973
UTCc3E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	Inverse variance weighted	6.98117931988492	12	0.858854792426404
UTCc3E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int_imputed.txt_snps.txt	Unweighted regression	0.00528546871073469	12	1
UTCc3E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	Maximum likelihood	9.45852199239508	12	0.663347466156206
UTCc3E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	MR Egger	9.49921466624071	11	0.575913563662413
UTCc3E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	Inverse variance weighted	9.50212484894575	12	0.659548709032912
UTCc3E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int_imputed.txt_snps.txt	Unweighted regression	0.0185103036964962	12	0.999999999999999
UTCc3E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	Maximum likelihood	7.74133521951632	12	0.805003441480146
UTCc3E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	MR Egger	6.45620925987024	11	0.841258866396571
UTCc3E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	Inverse variance weighted	7.74516750539642	12	0.804714181880208
UTCc3E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int_imputed.txt_snps.txt	Unweighted regression	0.0457352056132715	12	0.999999999999805
UVQFiE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.4966863827339	26	0.0544194685741388
UVQFiE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	MR Egger	37.4069157401079	25	0.0527986495532907
UVQFiE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.5002092143097	26	0.0543779108366627
UVQFiE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0341126211842486	26	1
UVQFiE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.561287377964	26	0.0818193689694563
UVQFiE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	MR Egger	35.9915957253247	25	0.0717274794941177
UVQFiE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.5613087310543	26	0.0818190118544456
UVQFiE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0541360809785972	26	1
UVQFiE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	36.8740509085134	26	0.0767273826151606
UVQFiE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	MR Egger	36.6726008019006	25	0.0619958270852036
UVQFiE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	36.9927036908375	26	0.0748669931136376
UVQFiE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.372335072757611	26	1
UXjAaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.0244548847804	41	0.0337963761169799
UXjAaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	MR Egger	56.7740400897941	40	0.0413295683855699
UXjAaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.0374792786142	41	0.0337115765761546
UXjAaZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0430126113653073	41	1
UXjAaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	54.5272396718727	41	0.0767577840432249
UXjAaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	MR Egger	50.0613887085978	40	0.13230466579916
UXjAaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	54.5374511121242	41	0.0766234195073634
UXjAaZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0626868806628493	41	1
UXjAaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	59.400753898736	41	0.0314206000158616
UXjAaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	MR Egger	59.3184913416034	40	0.0251172056306976
UXjAaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	59.4225512104597	41	0.0312876118268496
UXjAaZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.494077457835365	41	1
Uz4kaF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	55.4117256218469	31	0.00450802012667238
Uz4kaF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	53.3936676526046	30	0.00536719513859982
Uz4kaF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	55.4142519483267	31	0.00450512758763357
Uz4kaF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0388465322444655	31	1
Uz4kaF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	51.6536263404604	31	0.0113735648830916
Uz4kaF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	50.0965457567004	30	0.0121186050779647
Uz4kaF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	51.674402885157	31	0.0113174209096134
Uz4kaF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0596769727807763	31	1
Uz4kaF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	35.2236496325117	31	0.275023250136377
Uz4kaF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	32.1886906416889	30	0.358803941465926
Uz4kaF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	35.2396714661722	31	0.274400972787008
Uz4kaF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.313759446600406	31	1
v0kMCX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	68.6409381553878	56	0.119643622454798
v0kMCX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	67.907513158295	55	0.113480484268228
v0kMCX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	68.7060830841743	56	0.118574309682815
v0kMCX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0635489940337881	56	1
v0kMCX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.8624999811771	56	0.0644660710966686
v0kMCX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	72.8706668680738	55	0.0536947132970287
v0kMCX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.8711959967792	56	0.0643791806127082
v0kMCX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.117684147328815	56	1
v0kMCX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.548522201371	54	0.00745213156284325
v0kMCX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	82.6589491294414	53	0.00565666251961666
v0kMCX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.7128501187501	54	0.00720950006069661
v0kMCX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.969408629845985	54	1
V5RZQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.0794848073896	39	0.000993677989917312
V5RZQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	71.3582285946513	38	0.000844071463575082
V5RZQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.1074239864045	39	0.00098660754399356
V5RZQl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0542774493463206	39	1
V5RZQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	53.4771041772166	39	0.0611831640716971
V5RZQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	52.3185696861616	38	0.0609728890409251
V5RZQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	53.5060781669639	39	0.0608619509178403
V5RZQl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0644271060322865	39	1
V5RZQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	64.9227731310062	37	0.00305669979106982
V5RZQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	63.3953577872797	36	0.00321630713380247
V5RZQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	64.9493151933744	37	0.00303688405012032
V5RZQl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.412323893037908	37	1
vAPIai	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	69.2226727752073	52	0.0552948382836191
vAPIai	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	MR Egger	66.714771384683	51	0.0688473233340945
vAPIai	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	69.2228571145214	52	0.0552931676410726
vAPIai	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0599906556642621	52	1
vAPIai	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	70.2928435613611	52	0.0462906480018351
vAPIai	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	MR Egger	66.2866549011216	51	0.0736849215308963
vAPIai	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	70.2969251397157	52	0.0462588678910992
vAPIai	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0874946964740852	52	1
vAPIai	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	68.2316816742924	52	0.0649148508252097
vAPIai	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	MR Egger	67.1350792299452	51	0.0643580231021846
vAPIai	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	68.2346228728543	52	0.064884347729932
vAPIai	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.512163626903084	52	1
vbLSPq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	Maximum likelihood	23.0797200698201	18	0.187545217775125
vbLSPq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	MR Egger	17.7684828055426	17	0.403585479488651
vbLSPq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	Inverse variance weighted	23.0894285193209	18	0.187176933861037
vbLSPq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int_imputed.txt_snps.txt	Unweighted regression	0.0118969647167097	18	1
vbLSPq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	Maximum likelihood	30.2862700868187	18	0.0347545695387931
vbLSPq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	MR Egger	25.3255727068658	17	0.087655937169438
vbLSPq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	Inverse variance weighted	30.3128774640456	18	0.0345134482860398
vbLSPq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int_imputed.txt_snps.txt	Unweighted regression	0.0213516612109126	18	1
vbLSPq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	Maximum likelihood	12.2446995211654	18	0.834349923719391
vbLSPq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	MR Egger	12.2017753206681	17	0.787767873536362
vbLSPq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	Inverse variance weighted	12.2480266906391	18	0.834171243066961
vbLSPq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int_imputed.txt_snps.txt	Unweighted regression	0.108873217966103	18	1
vL13AU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	67.4431566705741	49	0.0413120296980752
vL13AU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	MR Egger	66.2826895102438	48	0.0411908805880254
vL13AU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	67.4461896769391	49	0.0412900943084764
vL13AU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0593938768602479	49	1
vL13AU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	60.2344435827375	49	0.1304317732783
vL13AU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	MR Egger	56.6116192823111	48	0.184485625102916
vL13AU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.2383958937474	49	0.13035801756761
vL13AU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.10044132724752	49	1
vL13AU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	39.15955442581	49	0.84159932897534
vL13AU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	MR Egger	39.1805788423478	48	0.814027361520503
vL13AU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	39.2007626386394	49	0.840428205804523
vL13AU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.674754654110854	49	1
vMEQAp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	59.7246723511952	35	0.00570909569161472
vMEQAp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	MR Egger	59.7142596473122	34	0.00415714417790838
vMEQAp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	59.7317389814067	35	0.00569941999004046
vMEQAp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0521870775768412	35	1
vMEQAp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	56.5376993023896	35	0.0120196413262827
vMEQAp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	MR Egger	56.2647234275015	34	0.0095357858578422
vMEQAp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	56.5400037764438	35	0.0120133554573253
vMEQAp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0873529166747625	35	1
vMEQAp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	30.6625007781968	34	0.631999729905189
vMEQAp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	MR Egger	27.0302118642883	33	0.758354542295404
vMEQAp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	30.7481723217864	34	0.62780651082948
vMEQAp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.23629686544645	34	1
vS7EhW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	Maximum likelihood	6.16858860445858	7	0.520208017568145
vS7EhW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	MR Egger	1.56136969274977	6	0.955314257773505
vS7EhW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	Inverse variance weighted	6.23568076299492	7	0.512515604617882
vS7EhW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int_imputed.txt_snps.txt	Unweighted regression	0.00315395931134231	7	0.999999999986627
vS7EhW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	Maximum likelihood	6.02500845002827	7	0.53683229509126
vS7EhW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	MR Egger	3.48242123331375	6	0.746306986886498
vS7EhW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	Inverse variance weighted	6.11947176257729	7	0.525870682668707
vS7EhW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int_imputed.txt_snps.txt	Unweighted regression	0.003698690170864	7	0.99999999997665
vS7EhW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	Maximum likelihood	3.88191043386259	7	0.79327419777002
vS7EhW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	MR Egger	3.88298141537035	6	0.692508575532679
vS7EhW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	Inverse variance weighted	3.88330240416777	7	0.793116378539624
vS7EhW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int_imputed.txt_snps.txt	Unweighted regression	0.0136042256258571	7	0.99999999778021
VWNbiq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	53.8930761456294	49	0.292675168903357
VWNbiq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	53.8541799303352	48	0.260359363454569
VWNbiq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	53.9045945423073	49	0.292300238263875
VWNbiq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.048716286731613	49	1
VWNbiq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	45.4374022607638	49	0.618355351790635
VWNbiq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	45.3963180046914	48	0.580151224713435
VWNbiq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	45.4375928579821	49	0.618347640009677
VWNbiq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0672140989461149	49	1
VWNbiq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	49.7094659895753	48	0.405028734343125
VWNbiq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	49.6588459193113	47	0.367777602024925
VWNbiq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	49.7112527776379	48	0.404959762775434
VWNbiq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.505103690645455	48	1
W1rSxc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	62.5553568435863	54	0.198556732742818
W1rSxc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	62.5491538821667	53	0.173379720147232
W1rSxc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	62.5592441197376	54	0.198462261578172
W1rSxc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0719598000197418	54	1
W1rSxc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	44.6721413149179	54	0.813268308294366
W1rSxc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	44.6252470456361	53	0.786696489568859
W1rSxc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	44.676026708034	54	0.813154388539725
W1rSxc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0629187229344581	54	1
W1rSxc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	Maximum likelihood	77.3706184126038	53	0.016134110791925
W1rSxc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	MR Egger	77.3840752920216	52	0.0127461883880754
W1rSxc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	77.3841922450516	53	0.0160927361526012
W1rSxc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.764110119106485	53	1
w8GjQi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	57.1190360294211	43	0.073234961668087
w8GjQi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	54.6860573105405	42	0.0907251886001251
w8GjQi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	57.1190603817244	43	0.0732346593168753
w8GjQi	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0717725004419924	43	1
w8GjQi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	59.1477914752095	43	0.0514168518915547
w8GjQi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	58.5854104607717	42	0.0459605415090088
w8GjQi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	59.1503484065225	43	0.0513933122548466
w8GjQi	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.102791459494594	43	1
w8GjQi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	Maximum likelihood	41.7957801583582	41	0.436084209618384
w8GjQi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	MR Egger	41.8428686644866	40	0.390774963553785
w8GjQi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	Inverse variance weighted	41.9253838579039	41	0.43053927250408
w8GjQi	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int_imputed.txt_snps.txt	Unweighted regression	0.414869173765764	41	1
wB9LxJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	52.7291188435629	48	0.296244081007297
wB9LxJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	MR Egger	51.5692075062877	47	0.299753639667831
wB9LxJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	52.7302996435383	48	0.296204985685311
wB9LxJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.0530133822745713	48	1
wB9LxJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	60.2910560399732	48	0.109770457830337
wB9LxJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	MR Egger	58.6808459008183	47	0.118037604760882
wB9LxJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	60.2923973005516	48	0.109748375528855
wB9LxJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.103883751309168	48	1
wB9LxJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	Maximum likelihood	65.1403446849597	47	0.0409218595506726
wB9LxJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	MR Egger	61.9223393694183	46	0.0584944380568242
wB9LxJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	Inverse variance weighted	65.1911614838701	47	0.0405525365912001
wB9LxJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int_imputed.txt_snps.txt	Unweighted regression	0.645464346501993	47	1
WPTdzg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	14.2644049663025	13	0.355490375996352
WPTdzg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	MR Egger	13.7613267728105	12	0.316208544995321
WPTdzg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	14.331370252464	13	0.350928088119319
WPTdzg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0113226980876586	13	1
WPTdzg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	13.3256764655049	13	0.422981917973375
WPTdzg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	MR Egger	13.4181185585054	12	0.339396267990658
WPTdzg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	13.4954255323368	13	0.410312008696136
WPTdzg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.00988031771614126	13	1
WPTdzg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.7629553219339	13	0.024795163656504
WPTdzg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	MR Egger	23.7504868017695	12	0.02198962201246
WPTdzg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	Inverse variance weighted	24.9315905819549	13	0.0235660682886161
WPTdzg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int_imputed.txt_snps.txt	Unweighted regression	0.202082016754587	13	0.999999999834384
wZC4hc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	Maximum likelihood	79.9092560023557	44	0.000750783388366319
wZC4hc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	MR Egger	79.8917771009004	43	0.00053754247125281
wZC4hc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	Inverse variance weighted	79.9112663993597	44	0.000750407863389908
wZC4hc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int_imputed.txt_snps.txt	Unweighted regression	0.0899922271630174	44	1
wZC4hc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	Maximum likelihood	71.6293047862154	44	0.0053022509762416
wZC4hc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	MR Egger	71.6289176935153	43	0.00397274693433807
wZC4hc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	Inverse variance weighted	71.6294780501789	44	0.0053020465690373
wZC4hc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int_imputed.txt_snps.txt	Unweighted regression	0.120203441617464	44	1
wZC4hc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	Maximum likelihood	45.3688615564	42	0.333405241264971
wZC4hc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	MR Egger	41.1086225305811	41	0.465862752045933
wZC4hc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	Inverse variance weighted	45.3867095230385	42	0.332733751776294
wZC4hc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int_imputed.txt_snps.txt	Unweighted regression	0.239656773917392	42	1
WZUmit	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	65.4701957761159	40	0.00672503682528527
WZUmit	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	MR Egger	64.8669465834158	39	0.00575851869903008
WZUmit	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	65.4758187512612	40	0.00671648276589866
WZUmit	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.0668932193704416	40	1
WZUmit	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	71.01291515088	40	0.00181534007392395
WZUmit	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	MR Egger	70.4595135389302	39	0.00149703074115382
WZUmit	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	71.0275195190649	40	0.00180883575048016
WZUmit	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.116175472654853	40	1
WZUmit	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	Maximum likelihood	35.6547383585826	39	0.623260548596737
WZUmit	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	MR Egger	33.668836653535	38	0.669938276704014
WZUmit	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	Inverse variance weighted	35.7523745094347	39	0.61880505405391
WZUmit	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int_imputed.txt_snps.txt	Unweighted regression	0.215253983150468	39	1
xI9GOc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	Maximum likelihood	37.2240456034047	30	0.170703909135188
xI9GOc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	MR Egger	34.3510512889321	29	0.22664183434688
xI9GOc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	Inverse variance weighted	37.2414200663399	30	0.170211850656936
xI9GOc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int_imputed.txt_snps.txt	Unweighted regression	0.0363361488069006	30	1
xI9GOc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	Maximum likelihood	39.6957026017454	30	0.110893762427
xI9GOc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	MR Egger	38.3074779168877	29	0.115649676941154
xI9GOc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	Inverse variance weighted	39.7526578809867	30	0.109744419757938
xI9GOc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int_imputed.txt_snps.txt	Unweighted regression	0.0740974435896165	30	1
xI9GOc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	Maximum likelihood	21.8896552328104	28	0.78637401802606
xI9GOc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	MR Egger	21.8926325364004	27	0.742813061677164
xI9GOc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	Inverse variance weighted	21.8933944747522	28	0.786202627323903
xI9GOc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int_imputed.txt_snps.txt	Unweighted regression	0.223851462723695	28	1
XrNAup	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.6725323451728	39	0.0997870712334383
XrNAup	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	49.1586284672184	38	0.106121460930037
XrNAup	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.6843847505717	39	0.0995896444583813
XrNAup	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0883952436602177	39	1
XrNAup	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	54.4405409935914	39	0.0512444224877819
XrNAup	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	53.7312807016468	38	0.0468062773073051
XrNAup	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	54.4483649735937	39	0.0511697498567482
XrNAup	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.128929677392735	39	1
XrNAup	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.3105509341532	36	0.0386427778824632
XrNAup	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	52.1621165670686	35	0.0310961520607094
XrNAup	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.4076348406011	36	0.0379001412516672
XrNAup	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.679818101734718	36	1
XuM3hA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	49.9973415502802	35	0.0481228044189922
XuM3hA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	45.7230349764559	34	0.0863304873538049
XuM3hA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.0301960849079	35	0.0478133862162986
XuM3hA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0461491165808616	35	1
XuM3hA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	54.5970775158032	35	0.0185198827344741
XuM3hA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	51.3986264228313	34	0.0282115283858146
XuM3hA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	54.6263579802272	35	0.0184017596270594
XuM3hA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0610140959067908	35	1
XuM3hA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Maximum likelihood	27.263156514403	34	0.786925549910877
XuM3hA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	MR Egger	26.6275534492564	33	0.775742613585701
XuM3hA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Inverse variance weighted	27.2955221863093	34	0.785602235198459
XuM3hA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int_imputed.txt_snps.txt	Unweighted regression	0.259849897023342	34	1
Xv8e6y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	63.9251094188696	37	0.00389606174097237
Xv8e6y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	MR Egger	63.4736603062649	36	0.00315477824246668
Xv8e6y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	63.9620395934523	37	0.00386147469078936
Xv8e6y	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0573318398054104	37	1
Xv8e6y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	53.3459538359858	37	0.0399808197084271
Xv8e6y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	MR Egger	53.3856192754982	36	0.0310910475462641
Xv8e6y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	53.4017946424747	37	0.0395438291275666
Xv8e6y	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0856090524492993	37	1
Xv8e6y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	38.258599073557	34	0.282149303457106
Xv8e6y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	MR Egger	36.4238669473063	33	0.312353396253877
Xv8e6y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	38.3285512053802	34	0.27951089815381
Xv8e6y	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.183810784928596	34	1
Y02RDa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	Maximum likelihood	55.1760114124268	40	0.0556471299346178
Y02RDa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	MR Egger	53.3136936288329	39	0.0630218175140607
Y02RDa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	55.1813913757053	40	0.0555925742449
Y02RDa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0658982099118953	40	1
Y02RDa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	Maximum likelihood	55.0181213110111	40	0.0572686916961
Y02RDa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	MR Egger	53.0876972385572	39	0.0656415504219054
Y02RDa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	55.0268378023483	40	0.0571781329160321
Y02RDa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.0830646563092629	40	1
Y02RDa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	Maximum likelihood	54.0103247787487	38	0.0443726293216787
Y02RDa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	MR Egger	53.9878742480821	37	0.035203758412163
Y02RDa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	Inverse variance weighted	54.0125031654155	38	0.0443540711856328
Y02RDa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int_imputed.txt_snps.txt	Unweighted regression	0.396735723411705	38	1
Y2KSlN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	46.9797705085183	26	0.00707324333148395
Y2KSlN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	MR Egger	46.8913908288091	25	0.00504970531731651
Y2KSlN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	47.0662448490561	26	0.00691476269933639
Y2KSlN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.062446446083795	26	1
Y2KSlN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	47.1630346973065	26	0.00674131495754659
Y2KSlN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	MR Egger	47.0213941421273	25	0.00487475598580355
Y2KSlN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	47.1792555517374	26	0.00671264809950509
Y2KSlN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.0804943101322877	26	1
Y2KSlN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	Maximum likelihood	32.1211445385352	23	0.0976501211225063
Y2KSlN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	MR Egger	32.1802616032637	22	0.0743742770651122
Y2KSlN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	Inverse variance weighted	32.199232039817	23	0.0960704676192318
Y2KSlN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int_imputed.txt_snps.txt	Unweighted regression	0.284856534695168	23	1
yccrR3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	39.7361937731416	28	0.0697877742726244
yccrR3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	MR Egger	36.3703195103266	27	0.10743393106169
yccrR3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	39.7563559839652	28	0.0695020824960418
yccrR3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.04060901480996	28	1
yccrR3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	43.0305411156046	28	0.0345694290909523
yccrR3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	MR Egger	42.0016960547753	27	0.0329026394806959
yccrR3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	43.0315259290486	28	0.0345618477398217
yccrR3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0661286412809052	28	1
yccrR3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	31.5158884150475	27	0.250488007790103
yccrR3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	MR Egger	31.3568002002845	26	0.2152484689195
yccrR3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	31.5716878003817	27	0.248318470396613
yccrR3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.253968549273221	27	1
YoOxqa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	66.9715591122206	42	0.00846924465816139
YoOxqa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	66.4331486632668	41	0.00721191741355721
YoOxqa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	66.9781828405292	42	0.00845699349623054
YoOxqa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0798619329248737	42	1
YoOxqa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	77.6671779490564	42	0.000671336105594174
YoOxqa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	75.2918089728498	41	0.000871203705256689
YoOxqa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	77.6673100190309	42	0.000671313585006711
YoOxqa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.218482723479856	42	1
YoOxqa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	Maximum likelihood	38.8360791863077	39	0.477266256674627
YoOxqa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	MR Egger	37.1579884312164	38	0.508217788338705
YoOxqa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	Inverse variance weighted	38.854272309616	39	0.476444818716605
YoOxqa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int_imputed.txt_snps.txt	Unweighted regression	0.364848315131167	39	1
yQ0PiJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	52.4958934159716	31	0.00929187685172988
yQ0PiJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	MR Egger	52.4988062005114	30	0.00672610620216175
yQ0PiJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	52.4993664187771	31	0.0092840746927732
yQ0PiJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0446629245593224	31	1
yQ0PiJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	39.2119971196803	31	0.147791397729109
yQ0PiJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	MR Egger	39.2211902982413	30	0.120850232968999
yQ0PiJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	39.2391876837811	31	0.147111182104248
yQ0PiJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0396995829586067	31	1
yQ0PiJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	44.3567361845172	30	0.0442552528221878
yQ0PiJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	MR Egger	43.4095326401679	29	0.0417104868487694
yQ0PiJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	44.3606756367114	30	0.0442185321092447
yQ0PiJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.226709244759582	30	1
YVmNIW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	116.383705787315	73	0.000941603944777674
YVmNIW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	MR Egger	115.606366278465	72	0.000852097539135841
YVmNIW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	116.399312115578	73	0.000938577441605921
YVmNIW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.129817475050574	73	1
YVmNIW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	122.021654406012	73	0.000283897605867783
YVmNIW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	MR Egger	121.925339791368	72	0.000218224749899633
YVmNIW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	122.075127873926	73	0.000280593253457171
YVmNIW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.215012342661912	73	1
YVmNIW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	92.6795582947313	69	0.0301991904839302
YVmNIW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	MR Egger	92.4742481607135	68	0.0258887905806671
YVmNIW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	92.7359122526765	69	0.0299302116829992
YVmNIW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.725976551303993	69	1
Z43pyp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.2176512953531	36	0.932767988558129
Z43pyp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	24.2821218283771	35	0.913026847237719
Z43pyp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	24.307924185328	36	0.930942643168398
Z43pyp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0308341441457329	36	1
Z43pyp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	24.9853826695619	36	0.916176288460252
Z43pyp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	25.0304940451498	35	0.893697369790999
Z43pyp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	25.0330824418598	36	0.915064739909164
Z43pyp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0489154426012162	36	1
Z43pyp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	50.3599525461464	35	0.0448021256678958
Z43pyp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	50.2690818151937	34	0.0357180737116875
Z43pyp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	50.376818505115	35	0.0446526444535183
Z43pyp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.486828475401441	35	1
z4o6XE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	82.1759185046405	55	0.0102288580973128
z4o6XE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	80.8920018751671	54	0.0103525364577829
z4o6XE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	82.1875481610252	55	0.0102057395581803
z4o6XE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0616761686044339	55	1
z4o6XE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	70.4407298866385	55	0.0784428447005025
z4o6XE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	69.7523147166612	54	0.0732417504483723
z4o6XE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	70.4547350199335	55	0.0782770322019246
z4o6XE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.0764256452595605	55	1
z4o6XE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.1274254473838	54	0.0502116376360901
z4o6XE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	MR Egger	71.9727257195948	53	0.042454940413545
z4o6XE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.1946566606717	54	0.0496615336404022
z4o6XE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int_imputed.txt_snps.txt	Unweighted regression	0.481883495137712	54	1
zaYbEI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	70.2048546910642	53	0.0568809945649299
zaYbEI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	70.1892563231449	52	0.0471034942491413
zaYbEI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	70.2136350550328	53	0.0568001810466574
zaYbEI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0785179879349822	53	1
zaYbEI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	65.4458117310827	53	0.117216675543774
zaYbEI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	65.3605430084507	52	0.100917292308065
zaYbEI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	65.4564432465946	53	0.117040229916634
zaYbEI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.124284815324321	53	1
zaYbEI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	48.6294993940738	52	0.607242075860551
zaYbEI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	MR Egger	47.9773283620316	51	0.594452408202268
zaYbEI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	48.6532997588057	52	0.60630459202124
zaYbEI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.804425277692809	52	1
zBocw2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	76.9784651781781	60	0.0689675509063384
zBocw2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	MR Egger	72.6229706187886	59	0.10951396485699
zBocw2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	76.9788233900255	60	0.0689638718323228
zBocw2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0845147905536743	60	1
zBocw2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	77.8145411300692	60	0.0608125109479736
zBocw2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	MR Egger	77.0450985081791	59	0.0574193685179241
zBocw2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	77.8160499263714	60	0.0607985569274544
zBocw2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.134334803502412	60	1
zBocw2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	80.8442252544171	56	0.0165680348579201
zBocw2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	MR Egger	75.7232494758361	55	0.0334045837792135
zBocw2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	80.873571978408	56	0.0164784773989619
zBocw2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.458939126999819	56	1
zL3ZxM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	82.9092477776836	49	0.00176680627143794
zL3ZxM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	80.2956332245575	48	0.00238966475550693
zL3ZxM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	82.9158327218325	49	0.00176413741744691
zL3ZxM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.0824656739813523	49	1
zL3ZxM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	79.1218258290213	49	0.00412323501791282
zL3ZxM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	76.8470237267583	48	0.00513342494901291
zL3ZxM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	79.1419489926195	49	0.00410520014121982
zL3ZxM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.115748862246691	49	1
zL3ZxM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	Maximum likelihood	59.965361856168	48	0.115237286195787
zL3ZxM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	MR Egger	55.2721171077933	47	0.190621121577392
zL3ZxM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	Inverse variance weighted	59.9991724273634	48	0.114660013946513
zL3ZxM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int_imputed.txt_snps.txt	Unweighted regression	0.447887484613901	48	1
ZPn7dV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	62.603022444136	58	0.316282057106925
ZPn7dV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	61.7134161973189	57	0.311390824213702
ZPn7dV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	62.6039124682594	58	0.316254133229386
ZPn7dV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.056156167295528	58	1
ZPn7dV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	52.7465214891944	58	0.670358410117463
ZPn7dV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	51.6004980463253	57	0.677107696486584
ZPn7dV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	52.7590818695591	58	0.669908897832336
ZPn7dV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	0.0761306046048104	58	1
ZPn7dV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	Maximum likelihood	87.9885082191339	58	0.00673061731326336
ZPn7dV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	MR Egger	87.9753975220985	57	0.00527186303452674
ZPn7dV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	Inverse variance weighted	88.0131804931936	58	0.00669790661977006
ZPn7dV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int_imputed.txt_snps.txt	Unweighted regression	1.04814510028659	58	1
ZQjLhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	85.2023798604479	66	0.0560320908980463
ZQjLhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	MR Egger	84.9779696256743	65	0.0488189837483041
ZQjLhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	85.2305531798469	66	0.0557987941420109
ZQjLhN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.0718185399887742	66	1
ZQjLhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	86.4634040332311	66	0.046361650966218
ZQjLhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	MR Egger	86.5300029021327	65	0.0383868003089446
ZQjLhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	86.5406872896179	66	0.0458182896426686
ZQjLhN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.101007985681509	66	1
ZQjLhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	Maximum likelihood	81.2968156532326	65	0.0834611075127641
ZQjLhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	MR Egger	79.6163630524861	64	0.0901904119140002
ZQjLhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	Inverse variance weighted	81.3191680273355	65	0.0832020839276665
ZQjLhN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int_imputed.txt_snps.txt	Unweighted regression	0.58573299451092	65	1
ztGqNt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	Maximum likelihood	90.8815212544506	47	0.000128705244717963
ztGqNt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	MR Egger	90.8809161368835	46	8.93305068849686e-05
ztGqNt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	Inverse variance weighted	90.9046172803561	47	0.000127929309193674
ztGqNt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int_imputed.txt_snps.txt	Unweighted regression	0.097192815290093	47	1
ztGqNt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	Maximum likelihood	75.4067832729495	47	0.00533426328170854
ztGqNt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	MR Egger	75.4282006879044	46	0.00401379380635253
ztGqNt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	Inverse variance weighted	75.4282776927738	47	0.00530941656600072
ztGqNt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int_imputed.txt_snps.txt	Unweighted regression	0.118784433827853	47	1
ztGqNt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	Maximum likelihood	66.2536322555241	46	0.0267862086063786
ztGqNt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	MR Egger	56.5315322175183	45	0.116265757489354
ztGqNt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	Inverse variance weighted	66.2555126391865	46	0.0267766687640487
ztGqNt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int_imputed.txt_snps.txt	Unweighted regression	0.393034591343023	46	1
Zv4w9a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	86.2092448440624	46	0.000302564525198931
Zv4w9a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	85.8026666734168	45	0.00023663204292922
Zv4w9a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	86.2155024756843	46	0.000302081793607732
Zv4w9a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.148886679552099	46	1
Zv4w9a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	72.1049369736592	46	0.00827071403943901
Zv4w9a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	71.3255633691843	45	0.007474119667873
Zv4w9a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	72.1962309521131	46	0.00811223668487973
Zv4w9a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.154099493696377	46	1
Zv4w9a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Maximum likelihood	52.8088547455386	41	0.102304458014913
Zv4w9a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	MR Egger	45.9412399319191	40	0.239567760168845
Zv4w9a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Inverse variance weighted	52.8257429409808	41	0.102023541188305
Zv4w9a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int_imputed.txt_snps.txt	Unweighted regression	0.453025766999279	41	1
ZVlai7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	56.1044926293086	34	0.00989901502061333
ZVlai7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	MR Egger	53.8888233465263	33	0.0122988251486519
ZVlai7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	56.1157309691223	34	0.00987312842667151
ZVlai7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0500035980209457	34	1
ZVlai7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	55.5833341767894	34	0.0111704695051331
ZVlai7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	MR Egger	53.3440014579255	33	0.0139422938452098
ZVlai7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	55.621407816426	34	0.0110727261039324
ZVlai7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.0862759830713709	34	1
ZVlai7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	Maximum likelihood	35.0171883375946	32	0.326813177859368
ZVlai7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	MR Egger	27.6462312859074	31	0.639364003169491
ZVlai7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	Inverse variance weighted	35.0607530007488	32	0.324968974270221
ZVlai7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int_imputed.txt_snps.txt	Unweighted regression	0.237285787990764	32	1
